TW200907513A - Liquid crystal alignment agent and liquid crystal display device - Google Patents

Liquid crystal alignment agent and liquid crystal display device Download PDF

Info

Publication number
TW200907513A
TW200907513A TW097118604A TW97118604A TW200907513A TW 200907513 A TW200907513 A TW 200907513A TW 097118604 A TW097118604 A TW 097118604A TW 97118604 A TW97118604 A TW 97118604A TW 200907513 A TW200907513 A TW 200907513A
Authority
TW
Taiwan
Prior art keywords
liquid crystal
crystal alignment
alignment agent
group
above formula
Prior art date
Application number
TW097118604A
Other languages
Chinese (zh)
Inventor
Hiroyuki Yasuda
Eiji Hayashi
Michinori Nishikawa
Original Assignee
Jsr Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Jsr Corp filed Critical Jsr Corp
Publication of TW200907513A publication Critical patent/TW200907513A/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C09DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
    • C09KMATERIALS FOR MISCELLANEOUS APPLICATIONS, NOT PROVIDED FOR ELSEWHERE
    • C09K19/00Liquid crystal materials
    • C09K19/52Liquid crystal materials characterised by components which are not liquid crystals, e.g. additives with special physical aspect: solvents, solid particles
    • C09K19/54Additives having no specific mesophase characterised by their chemical composition
    • C09K19/56Aligning agents
    • CCHEMISTRY; METALLURGY
    • C08ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08GMACROMOLECULAR COMPOUNDS OBTAINED OTHERWISE THAN BY REACTIONS ONLY INVOLVING UNSATURATED CARBON-TO-CARBON BONDS
    • C08G73/00Macromolecular compounds obtained by reactions forming a linkage containing nitrogen with or without oxygen or carbon in the main chain of the macromolecule, not provided for in groups C08G12/00 - C08G71/00
    • C08G73/06Polycondensates having nitrogen-containing heterocyclic rings in the main chain of the macromolecule
    • C08G73/10Polyimides; Polyester-imides; Polyamide-imides; Polyamide acids or similar polyimide precursors
    • CCHEMISTRY; METALLURGY
    • C08ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08LCOMPOSITIONS OF MACROMOLECULAR COMPOUNDS
    • C08L79/00Compositions of macromolecular compounds obtained by reactions forming in the main chain of the macromolecule a linkage containing nitrogen with or without oxygen or carbon only, not provided for in groups C08L61/00 - C08L77/00
    • C08L79/04Polycondensates having nitrogen-containing heterocyclic rings in the main chain; Polyhydrazides; Polyamide acids or similar polyimide precursors
    • C08L79/08Polyimides; Polyester-imides; Polyamide-imides; Polyamide acids or similar polyimide precursors
    • GPHYSICS
    • G02OPTICS
    • G02FOPTICAL DEVICES OR ARRANGEMENTS FOR THE CONTROL OF LIGHT BY MODIFICATION OF THE OPTICAL PROPERTIES OF THE MEDIA OF THE ELEMENTS INVOLVED THEREIN; NON-LINEAR OPTICS; FREQUENCY-CHANGING OF LIGHT; OPTICAL LOGIC ELEMENTS; OPTICAL ANALOGUE/DIGITAL CONVERTERS
    • G02F1/00Devices or arrangements for the control of the intensity, colour, phase, polarisation or direction of light arriving from an independent light source, e.g. switching, gating or modulating; Non-linear optics
    • G02F1/01Devices or arrangements for the control of the intensity, colour, phase, polarisation or direction of light arriving from an independent light source, e.g. switching, gating or modulating; Non-linear optics for the control of the intensity, phase, polarisation or colour 
    • G02F1/13Devices or arrangements for the control of the intensity, colour, phase, polarisation or direction of light arriving from an independent light source, e.g. switching, gating or modulating; Non-linear optics for the control of the intensity, phase, polarisation or colour  based on liquid crystals, e.g. single liquid crystal display cells
    • G02F1/133Constructional arrangements; Operation of liquid crystal cells; Circuit arrangements
    • G02F1/1333Constructional arrangements; Manufacturing methods
    • G02F1/1337Surface-induced orientation of the liquid crystal molecules, e.g. by alignment layers
    • G02F1/133711Surface-induced orientation of the liquid crystal molecules, e.g. by alignment layers by organic films, e.g. polymeric films
    • G02F1/133723Polyimide, polyamide-imide

Landscapes

  • Chemical & Material Sciences (AREA)
  • Physics & Mathematics (AREA)
  • Organic Chemistry (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Medicinal Chemistry (AREA)
  • Polymers & Plastics (AREA)
  • Nonlinear Science (AREA)
  • Health & Medical Sciences (AREA)
  • Mathematical Physics (AREA)
  • Spectroscopy & Molecular Physics (AREA)
  • General Physics & Mathematics (AREA)
  • Optics & Photonics (AREA)
  • Engineering & Computer Science (AREA)
  • Materials Engineering (AREA)
  • Macromolecular Compounds Obtained By Forming Nitrogen-Containing Linkages In General (AREA)
  • Liquid Crystal (AREA)
  • Compositions Of Macromolecular Compounds (AREA)

Abstract

TTo provide a liquid crystal alignment agent, which makes a polyimide-based liquid crystal alignment film to maintain the voltage holding ratio while reducing accumulated charges and further has outstanding printability, as well as a liquid crystal display element using the same. The aforementioned liquid crystal alignment agent is a polyimide-based liquid crystal alignment agent comprising a compound represented by the following formula (1). (In formula, two R1 are respectively and independently hydrogen, alkyl group, alkoxyl group or amino group; Y is any one of -S-, -NH-, -O-, -CH2- or single bonding; X1 and X2 are respectively and independently any one of the following structure. ) (In formula, Z1, Z2 and Z3 are respectively and independently hydrogen, alkyl group, alkoxyl group, amino group or diglycidylamino group. )

Description

200907513 九、發明說明: 【發明所屬之技術領域】 本發明涉及用於液晶顯示元件以及形成其 的液晶配向劑。更具體地說,涉及能夠形成印 性能優良的液晶配向膜的液晶配向劑以及採用 膜的液晶顯示元件。 【先前技術】 目前,作爲液晶顯示元件,已知具有所謂 列)型液晶胞的TN型液晶顯示元件,其在設置 膜的基板表面上形成由聚醯胺酸或聚醯亞胺等 配向膜,作爲液晶顯示元件用的基板,將2片 設置,在其間隙內形成具有正介電各向異性的 層,構成夾層結構的晶胞,液晶分子的長軸從 另一片基板連續地扭轉90度。並且,還開發1 晶顯示元件相比對比度更高、其視角依賴性S 超扭轉向列)型液晶顯示元件和垂直配向型液 。這種S TN型液晶顯示元件將在向列型液晶中 光學活性物質的手性劑的液晶作爲液晶使用, 使液晶分子的長軸在基板間處於連續扭轉1 8 0 的狀態而產生的雙折射效應。相比之下,如非 和專利文獻1所記載,又提出了在ITO上形成 液晶的配向方向的、被稱作爲MVA型的垂直配 示元件。Μ V A型液晶顯不兀件,不僅視角、對 ,而且在形成液晶配向膜的過程中可以不需 液晶配向膜 刷性和電學 該液晶配向 TN(扭曲向 了透明導電 形成的液晶 該基板相對 向列型液晶 一片基板向 _與TN型液 ΐ小的 STN( 晶顯示元件 摻合了作爲 其利用通過 度以上幅度 專利文獻1 突起以控製 向型液晶顯 比度等優良 要進行打磨 200907513 (rubbing)處理等,在製造製程方面也是優良的。作爲適用 於TN、STN、MVA型的液晶配向膜’要求有液晶顯示元件 的殘像消除時間短等性能。並且’作爲形成這些液晶配向 膜所用的配向劑,要求在乎版(〇ffset)印刷中具有優良的印 刷性。 【專利文獻1】日本特開平1 1 一 25 86〇5號公報 【非專利文獻1】“液晶”,V 〇 1. 3 N 〇 . 2,1 1 7 ( 1 9 9 9年)。 【發明内容】 本發明是鑑於上述問題而作出的,其目的是,提供在 使聚醯亞胺類液晶配向膜維持電壓保持率的同時又使其減 少蓄積電荷、並且具有優良的印刷性的液晶配向劑,以及 採用它的液晶顯示元件。 本發明的其他目的和優點可以由以下的說明看出。 根據本發明,本發明的上述目的和優點,第一,由一 種液晶配向劑達成,其特徵在於包括:由下述式(A)表示的 重複單元所構成的聚醯胺酸與由下述式(B)表示的重複單 元所構成的聚醯亞胺的混合物,或者由下述式(B)表示的重 複單元所構成的聚醯亞胺;以及下述式(1)表示的化合物(以 下也稱爲“特定化合物”)。200907513 IX. Description of the Invention: TECHNICAL FIELD The present invention relates to a liquid crystal display element and a liquid crystal alignment agent forming the same. More specifically, it relates to a liquid crystal alignment agent capable of forming a liquid crystal alignment film excellent in printing performance and a liquid crystal display element using the film. [Prior Art] At present, as a liquid crystal display element, a TN type liquid crystal display element having a so-called column type liquid crystal cell is known, which forms an alignment film such as polyacrylamide or polyimine on the surface of a substrate on which a film is provided. As a substrate for a liquid crystal display element, two sheets were provided, and a layer having positive dielectric anisotropy was formed in the gap to form a unit cell having a sandwich structure, and the long axis of the liquid crystal molecules was continuously twisted by 90 degrees from the other substrate. Further, a liquid crystal display element and a vertical alignment type liquid having a higher contrast ratio and a viewing angle-dependent S-hyper twisted nematic liquid crystal display element have been developed. In the S TN type liquid crystal display device, a liquid crystal of a chiral agent of an optically active substance in a nematic liquid crystal is used as a liquid crystal, and a birefringence is generated in which a long axis of the liquid crystal molecules is continuously twisted by 180 degrees between the substrates. effect. In contrast, as described in Patent Document 1, a vertical display element called an MVA type in which an alignment direction of liquid crystal is formed on ITO is proposed. VA VA type liquid crystal display, not only the viewing angle, the pair, but also in the process of forming the liquid crystal alignment film, the liquid crystal alignment film and the liquid crystal alignment TN are not required (the liquid crystal is twisted toward the transparent conductive substrate) One of the liquid crystal liquid crystal substrates is smothered with TN type liquid crystals (the crystal display element is blended as the use degree of the above-mentioned degree of use, and the patent document 1 is raised to control the apparent liquid crystal display ratio, etc.) 200907513 (rubbing) It is also excellent in the manufacturing process, etc. As a liquid crystal alignment film suitable for TN, STN, and MVA type, it is required to have a residual image erasing time of a liquid crystal display element, etc., and 'as an alignment for forming these liquid crystal alignment films. In addition, it is required to have excellent printability in the printing of the 版 set set 。 。 。 。 。 。 。 。 。 。 。 。 。 。 。 【 【 非 非 非 非 非 非 非 非 非 非 非 非 非 非 非 非 非 非 非 非 非 非 液晶 液晶 液晶 液晶 液晶,. 2,1 1 7 (1 9 9 9). SUMMARY OF THE INVENTION The present invention has been made in view of the above problems, and an object thereof is to provide a polyimine-based liquid crystal alignment A liquid crystal alignment agent which maintains a voltage holding ratio while reducing accumulated charges and having excellent printability, and a liquid crystal display element using the same. Other objects and advantages of the present invention can be seen from the following description. The above object and advantages of the present invention, first, achieved by a liquid crystal alignment agent, comprising: a polylysine composed of a repeating unit represented by the following formula (A) and having the following formula (B) a mixture of polyimine composed of a repeating unit represented by the above, or a polyimine composed of a repeating unit represented by the following formula (B); and a compound represented by the following formula (1) (hereinafter also referred to as " Specific compound").

(A) (P1爲4價的有機基團,且Q1爲2價的有機基團)。 200907513(A) (P1 is a tetravalent organic group, and Q1 is a divalent organic group). 200907513

(式中,2個R1各自獨立地爲氫、烷基、烷氧基或胺基’ γ爲_3_、-NH-、-Ο-、-CH2-或單鍵中的任意一種,X1和 X2各自獨立地爲下述結構中的任意一種)°(wherein 2 R1 are each independently hydrogen, alkyl, alkoxy or amino group 'γ is _3_, -NH-, -Ο-, -CH2- or a single bond, X1 and X2 Each of them is independently one of the following structures)

胺基或二縮水甘油基胺基)° 較佳爲上述式(1)中2個R1均爲氫、且Z1、Z2或Z3 任一者爲二縮水甘油基胺基的特定化合物或者上述式(1) 中2個R1均爲氫、且Z1、Z2或Z3任一者爲氫的特定化合 物。 另外較佳爲上述式(A)中的P1和上述式(B)中的p2均來 自於2,3,5 -三羧基環戊基醋酸二酐。 根據本發明,本發明的上述目的和優點,第二,由一 200907513 種液晶配向劑達成,其特徵在於包括:由上述式(A)表示的 重複單元所構成的聚醯胺酸與由上述式(B)表示的重複¥ 元所構成的聚醯亞胺的混合物,或者由上述式(B)表示的重 複單元所構成的聚醯亞胺;以及由上述式(1)中2個Rl^ 爲氫、且Z1、Z2或Z3均爲胺基的化合物與四竣酸二肝反 應所得的聚醯胺酸聚合物。 根據本發明,本發明的上述目的和優點,第三,由_ 種液晶顯示元件達成,其特徵在於具有由本發明的上述液 晶配向劑製得的液晶配向膜。 【實施方式】 以下對本發明進行詳細的說明。 本發明的液晶配向劑由特定化合物和聚醯亞胺,或者 特定化合物和聚醯胺酸以及聚醯亞胺所構成。 [特定化合物]The amine group or the diglycidylamino group) is preferably a specific compound in which two R1 in the above formula (1) are hydrogen, and any one of Z1, Z2 or Z3 is a diglycidylamino group or the above formula ( 1) A specific compound in which both R1 are hydrogen and any of Z1, Z2 or Z3 is hydrogen. Further, it is preferred that P1 in the above formula (A) and p2 in the above formula (B) are each derived from 2,3,5-tricarboxycyclopentyl acetic acid dianhydride. According to the present invention, the above objects and advantages of the present invention, and secondly, are achieved by a liquid crystal alignment agent of 200907513, characterized by comprising: a polylysine composed of a repeating unit represented by the above formula (A) and having the above formula (B) a mixture of polyimine composed of a repeating unit represented by (B) or a polyimine composed of a repeating unit represented by the above formula (B); and 2 R1^ of the above formula (1) A poly-proline polymer obtained by reacting a compound in which hydrogen and Z1, Z2 or Z3 are both an amine group and di-hepatic acid. According to the present invention, the above objects and advantages of the present invention, and thirdly, are achieved by a liquid crystal display element characterized by having a liquid crystal alignment film produced by the above liquid crystal alignment agent of the present invention. [Embodiment] Hereinafter, the present invention will be described in detail. The liquid crystal aligning agent of the present invention is composed of a specific compound and polyimine, or a specific compound and polyamine and polyimine. [specific compound]

R1 R1R1 R1

上述式(1)中,2個R1各自獨立地爲氫、烷基、烷氧基 或胺基。對其沒有特別的限製,其中烷基、烷氧基具體而 言,較佳爲碳數爲1〜6的烷基、碳數爲1~6的烷氧基。作 爲烷基和烷氧基中的烷基,可以舉出例如甲基、乙基、正 丙基、異丙基、正丁基、2-甲基-丙基、3-甲基-丙基、正戊 基、正己基。其中作爲R1,較佳爲氫、甲基。Y爲- S·、-NH-、 200907513 -0-、-CH2-或單鍵中的任意一種,其中較佳爲-S-、-NH-或 單鍵。X 1和X2爲下述結構中的任意一種。In the above formula (1), each of R1 is independently hydrogen, an alkyl group, an alkoxy group or an amine group. The alkyl group and the alkoxy group are specifically an alkyl group having 1 to 6 carbon atoms and an alkoxy group having 1 to 6 carbon atoms. Examples of the alkyl group in the alkyl group and the alkoxy group include a methyl group, an ethyl group, a n-propyl group, an isopropyl group, a n-butyl group, a 2-methyl-propyl group, and a 3-methyl-propyl group. N-pentyl, n-hexyl. Among them, R1 is preferably hydrogen or methyl. Y is any one of -S., -NH-, 200907513 -0-, -CH2- or a single bond, of which -S-, -NH- or a single bond is preferred. X 1 and X 2 are any of the following structures.

其中較佳爲下述結構中的任一種。Among them, preferred is any of the following structures.

上述式中,Z、Z2和Z3各自獨立地爲氫、烷基、烷氧 基、胺基或二縮水甘油基胺基。其中較佳爲氫、胺基或二 縮水甘油基胺基。 作爲具體的化合物,可以舉出In the above formula, Z, Z2 and Z3 are each independently hydrogen, an alkyl group, an alkoxy group, an amine group or a diglycidylamino group. Among them, preferred are hydrogen, an amine group or a diglycidylamino group. As a specific compound, it can be mentioned

在本發明中,還可以使用由上述式(1)中2個R1均爲 -10- 200907513 氫且Z1、Z2或Z3均爲胺基的特定化合物(以下也稱爲“特 定二胺”)與四羧酸二酐反應所得的聚醯胺酸聚合物(以下 也稱爲“特定聚醯胺酸”)代替上述特定化合物。在這種特 定聚醯胺酸的合成時,作爲酸酐,對其沒有特別的限製, 較佳的可以舉出1,2,3,4-環丁烷四羧酸二酐、1,3-二甲基 -1,2,3,4-環丁烷四羧酸二酐、2,3,5-三羧基環戊基醋酸二 酐、5-(2,5-二氧代四氫-3-呋喃基)-3-甲基-3-環己烯-1,2-二 羧酸酐、l,3,3a,4,5,9b-六氫-5-(四氫-2,5-二氧代-3-呋喃 基萘[1,2-c]呋喃-1,3-二酮、順式-3,7-二丁基環辛-1,5-二 烯-1,2,5,6-四羧酸二酐、3,5,6-三羰基-2-羧基降冰片烷 -2:3,5:6-二酐、l,3,3a,4,5,9b-六氫-8-甲基-5-(四氫-2,5-二 氧代-3-呋喃基)-萘Π,2-^]呋喃-1,3-二酮、3-氧雜雙環[3.2.1] 辛烷_2,4-二酮-6-螺- 3’-(四氫呋喃-2’,5’-二酮)、均苯四酸 二酐等。這些酸酐可以兩種以上組合使用。 另外,除特定二胺以外,還可以倂用其他二胺化合物。 作爲較佳的其他二胺’可以舉出例如對苯二胺、4,4,-二胺 基二苯基甲烷、4,4’-二胺基二苯基硫醚、2,2’-二甲基-4,4,-二胺基聯苯、1,5-二胺基萘、2,7-二胺基芴、9,9-二甲基-2,7-二胺基芴、4,4’-二胺基二苯醚、2,2 -二[4-(4-胺基苯氧基) 苯基]丙院、9,9 -二(4_胺基苯基)苟、2,2-二[4-(4 -胺基苯氧 基)苯基]六氟丙烷、2,2-二(4-胺基苯基)六氟丙烷、4,4’-(對 伸苯基二異亞丙基)二苯胺、4,4’-(間伸苯基二異亞丙基)二 苯胺、1,4 -環己烷二胺、4,4’-亞甲基二(環己基胺)、1,4-二 (4-胺基苯氧基)苯、4,4’-二(4-胺基苯氧基)聯苯、2,6-二胺 -11- 200907513 基吡啶、3,4 -二胺基吡啶、2,4_二胺基嘧啶、3,6-二胺基吖 啶、3,6-二胺基咔唑、N-甲基-3,6-二胺基咔唑、N-乙基-3,6-二胺基咔唑、N-苯基-3,6-二胺基昨唑、N,N’-二(4-胺基苯 基)聯苯胺> 1-(3,5-二胺基苯基)-3-癸基琥珀醯亞胺、1-(3,5-二胺基苯基)-3 -十八烷基琥珀醯亞胺等。這些其他二胺可以 單獨或者兩種以上組合使用。 這些特定化合物和/或特定聚醯胺酸的混合比例,相對 於1 0 0重量份聚醯胺酸(特定聚醯胺酸除外)和聚醯亞胺的 合計量,較佳爲0.1〜40重量份,更佳爲0.1〜30重量份。 [由上述式(A)表示的重複單元所構成的聚醯胺酸] <四羧酸二酐> 作爲能夠產生上述式(A)中的P\4價的有機基團)的、 聚醯胺酸合成中所用的四羧酸二酐,可以舉出例如脂環式 四羧酸二酐、脂肪族四羧酸二酐和芳香族四羧酸二酐。其 中,較佳爲脂環式四羧酸二酐。作爲脂環式四羧酸二酐的 具體例子,可以舉出1,2,3,4-環丁烷四羧酸二酐、1,2-二甲 基-1,2,3,4-環丁烷四羧酸二酐、1,3-二甲基-1,2,3,4-環丁烷 四羧酸二酐、1,3-二氯-1,2,3,4-環丁烷四羧酸二酐、1,2,3,4-四甲基-1,2,3,4-環丁烷四羧酸二酐、1,2,3,4-環戊烷四羧酸 二酐、1,2,4,5-環己烷四羧酸二酐、3,3’,4,4’_二環己基四羧 酸二酐、順式-3,7-二丁基環辛-1,5-二烯-1,2,5,6-四羧酸二 酐、2,3, 5 -三羧基環戊基醋酸二酐、5-(2,5 -二氧代四氫- 3-呋喃基)-3-甲基-3-環己烯-1,2-二羧酸酐、3,5,6-三羰基-2-羧基降冰片烷-2 :3,5:6-二酐、2,3/,5-四氫呋喃四羧酸二 -12- 200907513 酐、1,3,3&,4,5,913-六氫-5(四氫-2,5-二氧代-3-呋喃基)-萘 [1,2-c] -呋喃-1,3 -二酮、1,3, 3a,4,5,9b -六氫-5-甲基-5(四氫 -2,5-二氧代-3-呋喃基)-萘[1,24]-呋喃-1,3-二酮、 1,3,3&,4,5,913-六氫-5-乙基-5(四氫-2,5-二氧代-3-呋喃基)-萘[l,2-c] -呋喃-1,3 -二酮、1,3,3&,4,5,91?-六氫-7-甲基-5(四 氫-2,5-二氧代-3-呋喃基)-萘[1,2-(>]-呋喃-1,3-二酮、 1,3,3&,4,5,915-六氫-7-乙基-5(四氫-2,5-二氧代-3-呋喃基)-萘[l,2-c]-呋喃-1,3-二酮、l,3,3a,4,5,9b -六氫-8-甲基-5(四 氫-2,5-二氧代-3-呋喃基)-萘[1,2-(:]-呋喃-1,3-二酮、 1,3,3&,4,5,91)-六氫-8-乙基-5(四氫-2,5-二氧代-3-呋喃基)-萘[l,2-c]-呋喃-1,3-二酮、1,3, 3a,4,5,9b-六氫-5,8-二甲基 -5(四氫-2,5-二氧代-3-呋喃基)-萘[1,2-〇]-呋喃-1,3-二酮、 雙環[2.2.2]-辛-7-烯-2,3,5,6-四羧酸二酐、3-氧雜雙環In the present invention, it is also possible to use a specific compound (hereinafter also referred to as "specific diamine") in which two R1 in the above formula (1) are all -10 200907513 hydrogen and Z1, Z2 or Z3 are both amine groups. The polyphthalic acid polymer (hereinafter also referred to as "specific poly-proline acid") obtained by the reaction of tetracarboxylic dianhydride replaces the above specific compound. In the synthesis of the specific polyamic acid, the acid anhydride is not particularly limited, and preferred examples thereof include 1,2,3,4-cyclobutanetetracarboxylic dianhydride and 1,3-diene. Methyl-1,2,3,4-cyclobutanetetracarboxylic dianhydride, 2,3,5-tricarboxycyclopentyl acetic acid dianhydride, 5-(2,5-dioxotetrahydro-3- Furyl)-3-methyl-3-cyclohexene-1,2-dicarboxylic anhydride, 1,3,3a,4,5,9b-hexahydro-5-(tetrahydro-2,5-dioxo -3-furylnaphthalene [1,2-c]furan-1,3-dione, cis-3,7-dibutylcyclooctane-1,5-diene-1,2,5,6 -tetracarboxylic dianhydride, 3,5,6-tricarbonyl-2-carboxynorbornane-2:3,5:6-dianhydride, 1,3,3a,4,5,9b-hexahydro-8 -Methyl-5-(tetrahydro-2,5-dioxo-3-furanyl)-naphthoquinone, 2-^]furan-1,3-dione, 3-oxabicyclo[3.2.1] Octane 2,4-dione-6-spiro-3'-(tetrahydrofuran-2',5'-dione), pyromellitic dianhydride, etc. These acid anhydrides may be used in combination of two or more. In addition to the specific diamine, other diamine compounds may be used. Preferred other diamines may, for example, be p-phenylenediamine, 4,4,-diaminodiphenylmethane, 4,4'-di. Aminodiphenyl sulfide 2,2'-Dimethyl-4,4,-diaminobiphenyl, 1,5-diaminonaphthalene, 2,7-diaminopurine, 9,9-dimethyl-2,7- Diamino hydrazine, 4,4'-diaminodiphenyl ether, 2,2-bis[4-(4-aminophenoxy)phenyl]propyl, 9,9-di(4-amino Phenyl) fluorene, 2,2-bis[4-(4-aminophenoxy)phenyl]hexafluoropropane, 2,2-bis(4-aminophenyl)hexafluoropropane, 4,4' -(p-phenylenediisopropylidene)diphenylamine, 4,4'-(m-phenylenediisopropylidene)diphenylamine, 1,4-cyclohexanediamine, 4,4'-Asia Methyl bis(cyclohexylamine), 1,4-bis(4-aminophenoxy)benzene, 4,4'-bis(4-aminophenoxy)biphenyl, 2,6-diamine- 11- 200907513 Pyridine, 3,4-diaminopyridine, 2,4-diaminopyrimidine, 3,6-diaminoacridine, 3,6-diaminocarbazole, N-methyl-3 ,6-Diaminocarbazole, N-ethyl-3,6-diaminocarbazole, N-phenyl-3,6-diaminocarbazol, N,N'-di(4-amino Phenyl)benzidine> 1-(3,5-Diaminophenyl)-3-indolyl succinimide, 1-(3,5-diaminophenyl)-3-octadecyl Amber succinimide, etc. These other diamines may be used alone or in combination of two or more. The mixing ratio of these specific compounds and/or specific polyaminic acid is preferably 0.1 in terms of the total amount of 100 parts by weight of polyglycolic acid (excluding specific polyamido acid) and polyamidiamine. It is preferably 40 parts by weight, more preferably 0.1 to 30 parts by weight. [Polyuric acid composed of a repeating unit represented by the above formula (A)] <tetracarboxylic dianhydride> as a polyvalent organic group capable of generating P\4 in the above formula (A) Examples of the tetracarboxylic dianhydride used in the synthesis of valine acid include alicyclic tetracarboxylic dianhydride, aliphatic tetracarboxylic dianhydride, and aromatic tetracarboxylic dianhydride. Among them, an alicyclic tetracarboxylic dianhydride is preferred. Specific examples of the alicyclic tetracarboxylic dianhydride include 1,2,3,4-cyclobutanetetracarboxylic dianhydride and 1,2-dimethyl-1,2,3,4-ring. Butane tetracarboxylic dianhydride, 1,3-dimethyl-1,2,3,4-cyclobutanetetracarboxylic dianhydride, 1,3-dichloro-1,2,3,4-cyclobutane Alkanetetracarboxylic dianhydride, 1,2,3,4-tetramethyl-1,2,3,4-cyclobutanetetracarboxylic dianhydride, 1,2,3,4-cyclopentanetetracarboxylic acid Dihydride, 1,2,4,5-cyclohexanetetracarboxylic dianhydride, 3,3',4,4'-dicyclohexyltetracarboxylic dianhydride, cis-3,7-dibutyl ring Oct-1,5-diene-1,2,5,6-tetracarboxylic dianhydride, 2,3,5-tricarboxycyclopentyl acetic acid dianhydride, 5-(2,5-dioxotetrahydrogen) 3- 3-furyl)-3-methyl-3-cyclohexene-1,2-dicarboxylic anhydride, 3,5,6-tricarbonyl-2-carboxynorbornane-2 :3,5:6- Dihydride, 2,3/,5-tetrahydrofurantetracarboxylic acid Di-12- 200907513 Anhydride, 1,3,3&,4,5,913-hexahydro-5(tetrahydro-2,5-dioxo-3- Furyl)-naphthalene[1,2-c]-furan-1,3-dione, 1,3,3a,4,5,9b-hexahydro-5-methyl-5(tetrahydro-2,5 -dioxo-3-furanyl)-naphthalene[1,24]-furan-1,3-dione, 1,3,3&,4,5,913-hexahydro-5-ethyl-5(tetrahydrogen) -2,5-dioxo-3-furan -Naphthalene [l,2-c]-furan-1,3-dione, 1,3,3&,4,5,91?-hexahydro-7-methyl-5 (tetrahydro-2, 5-dioxo-3-furanyl)-naphthalene [1,2-(>]-furan-1,3-dione, 1,3,3&,4,5,915-hexahydro-7-ethyl -5 (tetrahydro-2,5-dioxo-3-furanyl)-naphthalene [l,2-c]-furan-1,3-dione, l,3,3a,4,5,9b - Hexahydro-8-methyl-5(tetrahydro-2,5-dioxo-3-furanyl)-naphthalene [1,2-(:]-furan-1,3-dione, 1,3, 3&,4,5,91)-hexahydro-8-ethyl-5(tetrahydro-2,5-dioxo-3-furanyl)-naphthalene[l,2-c]-furan-1, 3-diketone, 1,3,3a,4,5,9b-hexahydro-5,8-dimethyl-5(tetrahydro-2,5-dioxo-3-furanyl)-naphthalene [1 ,2-〇]-furan-1,3-dione, bicyclo[2.2.2]-oct-7-ene-2,3,5,6-tetracarboxylic dianhydride, 3-oxabicyclo

-13- 200907513 和R5表示氫原子或者烷基,多個存在的R3和R5各自可以 相同,也可以不同)。 此外,還可以舉出丁烷四羧酸二酐等脂肪族四羧酸二 酐; 均苯四酸二酐、3,3’,4,4’-二苯酮四羧酸二酐、 3,3’,4,4’-聯苯基碾四羧酸二酐、1,4,5,8-萘四羧酸二酐、 2,3,6,7-萘四羧酸二酐、3,3’,4,4’-聯苯基醚四羧酸二酐、 3,3’,4,4’-二甲基二苯基矽烷四羧酸二酐、3,3’,4,4’-四苯基 矽烷四羧酸二酐、1,2,3,4-呋喃四羧酸二酐、4,4’-二(3,4-二羧基苯氧基)二苯基硫醚二酐、4,4’-二(3,4-二羧基苯氧基) 二苯基碾二酐、4,4’-二(3,4-二羧基苯氧基)二苯基丙烷二 酐、3,3’,4,4’-全氟異亞丙基二苯二甲酸二酐、2,2’,3,3’-聯 苯四羧酸二酐、3,3’,4,4’-聯苯四羧酸二酐、二(苯二甲酸) 苯膦氧化物二酐、對亞苯基-二(三苯基苯二甲酸)二酐、間 伸苯基-二(三苯基苯二甲酸)二酐、二(三苯基苯二甲' 酸)-4,4’-二苯醚二酐、二(三苯基苯二甲酸)-4,4’-二苯基甲 烷二酐、乙二醇-二(脫水偏苯三酸酯)、丙二醇-二(脫水偏 苯三酸酯)、1,4-丁二醇-二(脫水偏苯三酸酯)、1,6-己二醇-二(脫水偏苯三酸酯)、1,8-辛二醇-二(脫水偏苯三酸酯)、 2,2-二(4-羥苯基)丙烷-二(脫水偏苯三酸酯)、下述式(2)〜(5) 表示的化合物等芳香族四羧酸二酐。這些四羧酸二酐可以 一種單獨或兩種以上組合使用。 14- 200907513-13- 200907513 and R5 represent a hydrogen atom or an alkyl group, and a plurality of R3 and R5 present may be the same or different. Further, an aliphatic tetracarboxylic dianhydride such as butane tetracarboxylic dianhydride; pyromellitic dianhydride, 3,3',4,4'-benzophenonetetracarboxylic dianhydride, 3, 3',4,4'-biphenyltricarboxylic dianhydride, 1,4,5,8-naphthalenetetracarboxylic dianhydride, 2,3,6,7-naphthalenetetracarboxylic dianhydride, 3, 3',4,4'-biphenyl ether tetracarboxylic dianhydride, 3,3',4,4'-dimethyldiphenylnonane tetracarboxylic dianhydride, 3,3',4,4' - tetraphenylnonane tetracarboxylic dianhydride, 1,2,3,4-furan tetracarboxylic dianhydride, 4,4'-bis(3,4-dicarboxyphenoxy)diphenyl sulfide dianhydride 4,4'-bis(3,4-dicarboxyphenoxy)diphenyl succinic anhydride, 4,4'-bis(3,4-dicarboxyphenoxy)diphenylpropane dianhydride, 3 , 3',4,4'-perfluoroisopropylidene diphthalic dianhydride, 2,2',3,3'-biphenyltetracarboxylic dianhydride, 3,3',4,4'- Biphenyltetracarboxylic dianhydride, di(phthalic acid) phenylphosphine oxide dianhydride, p-phenylene-bis(triphenylphthalic acid) dianhydride, meta-phenyl-bis(triphenylbenzene) Formic acid) dianhydride, bis(triphenylphthalic acid)-4,4'-diphenyl ether dianhydride, bis(triphenyl phthalic acid) )-4,4'-diphenylmethane dianhydride, ethylene glycol-di(hydrogen trimellitate), propylene glycol-di(hydroper trimellitate), 1,4-butanediol-di Dehydrated trimellitate), 1,6-hexanediol-di(anhydrotrimellitic acid ester), 1,8-octanediol-di(hydrogen trimellitate), 2,2-di ( 4-hydroxyphenyl)propane-di(hydrogen trimellitate), an aromatic tetracarboxylic dianhydride such as a compound represented by the following formulas (2) to (5). These tetracarboxylic dianhydrides may be used alone or in combination of two or more. 14- 200907513

ίί

上述四羧酸二酐中,從能夠使其表現 性的角度出發,較佳爲1,2,3,4 -環丁烷四_ 甲基-1,2,3,4-環丁烷四羧酸二酐、1,2,3,4 良好的液晶配向 麥酸二酐、1 , 3 -二 -四甲基-1,2,3,4- -15- 200907513 環丁烷四羧酸二酐、1,2,3,4_環戊烷四羧酸二酐、2 3 5·三 羧基環戊基醋酸:酐、5·(2,5·:氧代四氣呋喃基)小甲 基-3-環己烯-1,2-二羧酸酐、5_(2,5-二氧代 基)-3 -甲基-3-環己烯-丨,^ 羧 四氫呋喃亞甲 酉干、順式-3,7 _二丁基環辛 -1,5 -二烯-12,5,6-四羧酸 3’5,6·Η羰基·2_羧基降冰 片烷-2:3,5:6-二酐、1,3,3&,4,5,9卜六氫_5(四氫_2,5_二氧代 -3 -呋喃基)-萘[l,2-c]呋喃 _丨,3_ 二酮、1,3,3&,4,5,9^六氫_8_ 甲基乃^四氫^一-二氧代-^呋喃基卜萘^^-叫呋喃-^-二 酮、l,3,3a,4,5,9b-/、氫 _5,8-二甲基-5-(四氫_2,5-二氧代-3_ 呋喃基)-萘[1,2_<:]呋喃-1,3-二酮、雙環[2.2.2]-辛-7-烯 -2,3,5,6 -四羧酸二酐、3-氧雜雙環[3.2.1]辛烷-2,4-二酮- 6-螺·3’-(四氫呋喃-2’,5’-二酮)、上述式(I)表示的化合物中的 下述式(6 )~( 8)表示的化合物等脂環式四羧酸二酐以及上述 式(II)表示的化合物中的下述式(9)表不的化合物等脂環式 四殘酸二肝’作爲特佳的’可以舉出1,4 -環丁院四殘酸 二酐、1,3-二甲基·1,2,3,4-環丁烷四竣酸二酐、2,3,5-三羧 基環戊基醋酸二酐、5-(2,5 -二氧代四氫·3_呋喃基)_3_甲基 -3-環己烯-1,2-二羧酸酐、1,3,3&,4,5,915-六氫-5-(四氫-2,5-二氧代-3-呋喃基)-萘[l,2-c]呋喃-1,3-—酮、順式_3,7·— 丁 基環辛-1,5-二烯_1,2,5,6-四羧酸二酐、3,5,6-二羰基_2_羧 基降冰片烷- 2:3,5:6-二酐、l,3,3a,4,5,9b_六氫_8_甲基 -5-(四氫- 2,5-二氧代_3-呋喃基萘[丨,2-。呋喃-1,3-一酮、 3-氧雜雙環[3 .2.1]辛烷_2,4-二酮_6_螺_3’-(四氫呋喃-2’,5’-二酮)和下述式(6)表示的化合物° -16 _ 200907513Among the above tetracarboxylic dianhydrides, preferred is 1,2,3,4-cyclobutane tetra-methyl-1,2,3,4-cyclobutane tetracarboxylic acid from the viewpoint of its performance. Acid dianhydride, 1,2,3,4 good liquid crystal alignment malic acid dianhydride, 1,3 -di-tetramethyl-1,2,3,4- -15- 200907513 cyclobutane tetracarboxylic dianhydride 1,2,3,4-cyclopentanetetracarboxylic dianhydride, 2 3 5 ·tricarboxycyclopentyl acetic acid: anhydride, 5·(2,5·: oxotetrahydrofuranyl) small methyl group- 3-cyclohexene-1,2-dicarboxylic anhydride, 5-(2,5-dioxo)-3-methyl-3-cyclohexene-oxime, carboxytetrahydrofuran, methylene hydrazide, cis- 3,7-Dibutylcyclooctane-1,5-diene-12,5,6-tetracarboxylic acid 3'5,6·Ηcarbonyl·2_carboxynorbornane-2:3,5:6- Dihydride, 1,3,3&,4,5,9-hexahydro-5 (tetrahydro-2,5-dioxo-3-furanyl)-naphthalene [l,2-c]furan-oxime, 3_dione, 1,3,3&,4,5,9^hexahydro_8_methyl is^tetrahydro^-dioxy-^furanylnaphthalene^^-called furan-^-dione, l,3,3a,4,5,9b-/,hydro-5,8-dimethyl-5-(tetrahydro-2,5-dioxo-3-furanyl)-naphthalene [1,2_<: Furan-1,3-dione, bicyclo[2.2.2]-oct-7-ene-2,3,5,6-tetracarboxylic acid Anhydride, 3-oxabicyclo[3.2.1]octane-2,4-dione-6-spiro-3'-(tetrahydrofuran-2',5'-dione), a compound represented by the above formula (I) In the alicyclic tetracarboxylic dianhydride such as a compound represented by the following formulas (6) to (8), and the compound represented by the following formula (9) in the compound represented by the above formula (II), an alicyclic four or the like Residual acid di-hepatic 'as a special one' can be exemplified by 1,4 -cyclobutanine tetraresidic acid dianhydride, 1,3-dimethyl-1,2,3,4-cyclobutane tetradecanoic acid dianhydride , 2,3,5-tricarboxycyclopentyl acetic acid dianhydride, 5-(2,5-dioxotetrahydro-3-furanyl)_3_methyl-3-cyclohexene-1,2-di Carboxylic anhydride, 1,3,3&,4,5,915-hexahydro-5-(tetrahydro-2,5-dioxo-3-furanyl)-naphthalene [l,2-c]furan-1,3 -ketone, cis_3,7·-butylcyclooctane-1,5-diene-1,2,5,6-tetracarboxylic dianhydride, 3,5,6-dicarbonyl_2-carboxyl Norbornane - 2:3,5:6-dianhydride, l,3,3a,4,5,9b_hexahydro_8-methyl-5-(tetrahydro-2,5-dioxo-3 -furanylnaphthalene [丨,2-.furan-1,3-one, 3-oxabicyclo[3.2.1]octane-2,4-dione_6_spiro_3'-(tetrahydrofuran-2 ',5'-dione) and represented by the following formula (6) Thereof ° -16 _ 200907513

脂環式四殘酸二酐以外的其他四翔酸二酐中作爲較佳 的,可以舉出例如丁烷四羧酸二酐、均苯四酸二酐、 3,3’,4,4’-聯苯酮四羧酸二酐、3,3’,4,4’-二苯基颯四羧酸二 酐、1,4,5,8-萘四羧酸二酐等。 這些四羧酸二酐中,較佳爲脂環式四羧酸二酐相對於 全部四羧酸二酐占50莫耳%以上。 <二胺> 作爲能夠產生上述式(A)中的Q】(2價的有機基團)的、 聚醯胺酸合成和/或其醯亞胺化聚合物中使用的特定二胺 以外的二胺’可以舉出例如對苯二胺、間苯二胺、4,4,_二 胺基—苯基甲院' 4,4,_二胺基二苯基乙烷、4,4,·二胺基二 -17- 200907513 苯基硫醚、4,4’-二胺基二苯基碾、3,3’-二甲基-4,4’-二胺 基聯苯、4,4’_二胺基苯甲醯苯胺、4,4’_二胺基二苯醚、1,5-二胺基萘、2,2’-二甲基-4,4’-二胺基聯苯、5-胺基 胺基苯基)-1,3,3-三甲基茚滿、6-胺基-1-(4’-胺基苯 基)-1,3,3-三甲基茚滿、3,4’-二胺基二苯基醚、3,3’-二胺基 二苯酮、3,4’-二胺基二苯酮、4,4’-二胺基二苯酮、2,2-二 [4-(4 -胺基苯氧基)苯基]丙烷、2,2 -二[4-(4 -胺基苯氧基)苯 基]六氟丙烷、2,2-二(4·胺基苯基)六氟丙烷、2,2-二[4-(4-胺基苯氧基)苯基]礪、1,4-二(4-胺基苯氧基)苯、1,3-二(4-胺基苯氧基)苯、1,3-二(3-胺基苯氧基)苯、9,9-二(4-胺基 苯基)-10-氫蒽、2,7-二胺基芴、9,9-二(4-胺基苯基)芴、4,4’-亞甲基-二(2-氯苯胺·)、2,2’,5,5’-四氯-4,4’-二胺基聯苯、 2,2’-二氯-4,4’-二胺基-5,5’-二甲氧基聯苯、3,3’-二甲氧基 -4,4’-二胺基聯苯、1,4,4’-(對伸苯基異亞丙基)二苯胺、 4,4’-(間伸苯基異亞丙基)二苯胺、2,2’-二[4-(4-胺基-2-三 氟甲基苯氧基)苯基]六氟丙烷、4,4’-二胺基-2,2’-二(三氟 甲基)聯苯、4,4’-二[(4-胺基-2-三氟甲基)苯氧基]-八氟聯 苯、Ν,Ν’-二(4-胺基苯基)聯苯胺等芳香族二胺; 1,1 -間苯二甲胺、1,3 -丙二胺、丁二胺、戊二胺、己 二胺 '庚二胺、辛二胺、壬二胺、4,4 -二胺基庚二胺、1,4 -二胺基環己烷、異佛爾酮二胺、四氫二環戊二烯二胺、三 環[6.2.1.〇2,7卜十一碳烯二甲二胺、4,4’-亞甲基二(環己胺 等脂肪族和脂環式二胺; 2,3 -二胺基吡啶、2,6 -二胺基吡啶、3,4 -二胺基吡啶、 -18- 200907513 2,4-二胺基嘧啶、5,6-二胺基-2,3-二氰基吡嗪、5,6-二胺基 -2,4 -二羥基嘧啶、2,4 -二胺基-6 -二甲基胺基-1 , 3,5 -三嗪、 1,4-二(3-胺基丙基)呱嗪、2,4-二胺基-6-異丙氧基-1,3,5-三 嗪、2,4-二胺基-6-甲氧基-1,3, 5-三嗪、2,4-二胺基-6-苯基 -1,3,5-三嗪、2,4-二胺基-6-甲基-s-三嗪、2,4-二胺基-1,3,5-三嗪、4,6-二胺基-2-乙烯基-s-三嗪、2,4-二胺基-5-苯基噻 唑、2,6 -二胺基嘌呤、5,6 -二胺基-1,3 -二甲基尿嘧啶、3,5 -二胺基-1,2,4-三唑、6,9-二胺基-2-乙氧基吖啶乳酸酯、3,8-二胺基-6 -苯基菲啶、1,4 -二胺基呱嗪、3,6 -二胺基吖啶、 二(4-胺基苯基)苯基胺、1-(3,5-二胺基苯基)-3-癸基琥珀醯 亞胺、1 - ( 3,5 -二胺基苯基)-3 -十八烷基琥珀醯亞胺以及下述 式(III)和(IV)各自表示的化合物等分子內具有2個1級胺 基以及該1級胺基以外的氮原子的二胺;Preferred among the tetracylene dianhydrides other than the alicyclic tetrahydro acid dianhydride are butane tetracarboxylic dianhydride, pyromellitic dianhydride, and 3,3', 4, 4'. -biphenonetetracarboxylic dianhydride, 3,3',4,4'-diphenylphosphonium tetracarboxylic dianhydride, 1,4,5,8-naphthalenetetracarboxylic dianhydride, and the like. Among these tetracarboxylic dianhydrides, the alicyclic tetracarboxylic dianhydride is preferably 50 mol% or more based on the total tetracarboxylic dianhydride. <Diamine> As a polyamine derivative capable of producing Q (a divalent organic group) in the above formula (A), and/or a specific diamine used in the ruthenium iodide polymer thereof The diamine' may, for example, be p-phenylenediamine, m-phenylenediamine, 4,4,-diamino-phenyl-methyl' 4,4,-diaminodiphenylethane, 4, 4, ·Diaminodi-17- 200907513 Phenyl sulfide, 4,4'-diaminodiphenyl milling, 3,3'-dimethyl-4,4'-diaminobiphenyl, 4,4 '_Diaminobenzimidanilide, 4,4'-diaminodiphenyl ether, 1,5-diaminonaphthalene, 2,2'-dimethyl-4,4'-diaminobiphenyl 5-aminoaminophenyl)-1,3,3-trimethylindan, 6-amino-1-(4'-aminophenyl)-1,3,3-trimethylhydrazine Full, 3,4'-diaminodiphenyl ether, 3,3'-diaminobenzophenone, 3,4'-diaminobenzophenone, 4,4'-diaminobenzophenone , 2,2-bis[4-(4-aminophenoxy)phenyl]propane, 2,2-bis[4-(4-aminophenoxy)phenyl]hexafluoropropane, 2,2 - bis(4-aminophenyl)hexafluoropropane, 2,2-bis[4-(4-aminophenoxy)phenyl]anthracene, 1,4-bis(4-aminophenoxy) benzene 1,3-bis(4-aminophenoxy)benzene, 1,3-bis(3-aminophenoxy)benzene, 9,9-bis(4-aminophenyl)-10-hydroquinone , 2,7-diaminopurine, 9,9-bis(4-aminophenyl)anthracene, 4,4'-methylene-bis(2-chloroaniline), 2,2',5, 5'-tetrachloro-4,4'-diaminobiphenyl, 2,2'-dichloro-4,4'-diamino-5,5'-dimethoxybiphenyl, 3,3' -dimethoxy-4,4'-diaminobiphenyl, 1,4,4'-(p-phenylisopropylene)diphenylamine, 4,4'-(meta-phenylene isopropylidene Diphenylamine, 2,2'-bis[4-(4-amino-2-trifluoromethylphenoxy)phenyl]hexafluoropropane, 4,4'-diamino-2,2' - bis(trifluoromethyl)biphenyl, 4,4'-bis[(4-amino-2-trifluoromethyl)phenoxy]-octafluorobiphenyl, anthracene, Ν'-di(4- Aromatic diamines such as aminophenyl)benzidine; 1,1-m-xylylenediamine, 1,3-propylenediamine, butanediamine, pentamethylenediamine, hexamethylenediamine, heptanediamine, octanediamine , hydrazine diamine, 4,4-diaminoheptyldiamine, 1,4 -diaminocyclohexane, isophorone diamine, tetrahydrodicyclopentadiene diamine, tricyclic [6.2.1 .〇2,7-undecene dimethyldiamine, 4,4'- Aliphatic and alicyclic diamines such as methyl bis(cyclohexylamine; 2,3-diaminopyridine, 2,6-diaminopyridine, 3,4-diaminopyridine, -18-200907513 2, 4-diaminopyrimidine, 5,6-diamino-2,3-dicyanopyrazine, 5,6-diamino-2,4-dihydroxypyrimidine, 2,4-diamino-6 -dimethylamino-1,3,5-triazine, 1,4-bis(3-aminopropyl)pyridazine, 2,4-diamino-6-isopropoxy-1,3 ,5-triazine, 2,4-diamino-6-methoxy-1,3,5-triazine, 2,4-diamino-6-phenyl-1,3,5-triazine , 2,4-diamino-6-methyl-s-triazine, 2,4-diamino-1,3,5-triazine, 4,6-diamino-2-vinyl-s - triazine, 2,4-diamino-5-phenylthiazole, 2,6-diaminopurine, 5,6-diamino-1,3-dimethyluracil, 3,5-di Amino-1,2,4-triazole, 6,9-diamino-2-ethoxyacridine lactate, 3,8-diamino-6-phenylphenanthridine, 1,4- Diaminopyridazine, 3,6-diaminoacridine, bis(4-aminophenyl)phenylamine, 1-(3,5-diaminophenyl)-3-indenyl amber Amine, 1-(3,5-diaminophenyl)-3-octadecyl amber quinone and the following formula (I a diamine having two first-order amine groups and a nitrogen atom other than the first-order amine group in a molecule such as a compound represented by II) and (IV);

(式中,R6表示選自吡啶、嘧啶、三嗪、呱啶以及呱嗪 的具有含氮原子環狀結構的1價有機基團,X3表示2價的 有機基團)。(wherein R6 represents a monovalent organic group having a cyclic structure containing a nitrogen atom selected from the group consisting of pyridine, pyrimidine, triazine, acridine and pyridazine, and X3 represents a divalent organic group).

(式中,X4表示選自吡啶、嘧啶、三嗪、呱啶以及呱嗪 的具有含氮原子環狀結構的2價有機基團,R7表示2價的 有機基團,多個存在的X4可以相同,也可以不同)。 -19- 200907513 下述式(V)表示的單取代苯二胺;下述式(VI)表示的二 胺基有機矽氧烷; /^===\^R8一R9 h2n^-^nh2 ...(V) (式中,R8 表示選自 _〇_、_C〇〇_、_〇C〇_、_NHcq 、 -CONH-以及- CO-的2價有機基團,R9表示具有選自固體骨 架、三氟甲基以及氟的基團的1價有機基團或者碳數爲 6〜30的院基)。(wherein X4 represents a divalent organic group having a cyclic structure containing a nitrogen atom selected from the group consisting of pyridine, pyrimidine, triazine, acridine and pyridazine, and R7 represents a divalent organic group, and a plurality of X4 present may be The same, can also be different). -19- 200907513 A monosubstituted phenylenediamine represented by the following formula (V); a diamine-based organodecane represented by the following formula (VI); /^===\^R8-R9 h2n^-^nh2 . (V) (wherein R8 represents a divalent organic group selected from the group consisting of _〇_, _C〇〇_, _〇C〇_, _NHcq, -CONH-, and -CO-, and R9 represents a solid selected from the group consisting of a monovalent organic group of a skeleton, a trifluoromethyl group, and a fluorine group or a hospital group having a carbon number of 6 to 30).

Ri〇 RioRi〇 Rio

(式中’ R1Q表示碳數爲1〜12的烴基,多個存在的Ri〇 各自可以相同’也可以不同,p爲1~3的整數,q爲1〜20 的整數)。 以及下述式(10)〜(14)各自表示的化合物等。這些二胺 化合物可以單獨或者兩種以上組合使用。 -20- 200907513(In the formula, R1Q represents a hydrocarbon group having a carbon number of 1 to 12, and a plurality of Ri(R) existing may be the same 'may be different, p is an integer of 1 to 3, and q is an integer of 1 to 20). And a compound represented by each of the following formulas (10) to (14). These diamine compounds may be used singly or in combination of two or more. -20- 200907513

(式中,y爲2〜12的整數,z爲1〜5的整數)。 其中,較佳爲對苯二胺、4,4’-二胺基二苯甲院 二胺基二苯硫醚、1,5-二胺基萘、2,7 -二胺基芴、4, 基二苯基醚、2,2-二[4-(4-胺基苯氧基)苯基]丙烷、9 胺基苯基)芴、2,2-二[4-(4-胺基苯氧基)苯基]六氟丙 、4,4,-4,-二胺 ,9-二(4-烷、2,2- -21- 200907513 二(4-胺基苯基)六氟丙烷、4,4’-(對伸苯基二異亞丙基)二苯 胺、4,4’-(間伸苯基二異亞丙基)二苯胺、1,4-環己烷二胺、 4,4’-亞甲基二(環己胺)、1,4-二(4-胺基苯氧基)苯、4,4’-二 (4-胺基苯氧基)聯苯、上述式(10)〜(14)各自表示的化合 物、2,6 -二胺基吡啶、3,4 -二胺基吡啶、2,4 -二胺基嘧啶、 3,6-二胺基吖啶、上述式(III)表示的化合物中的下述式(15) 表示的化合物、上述式(IV)表示的化合物中的下述式(16) 表示的化合物以及上述式(V)表示的化合物中的下述式 (17)〜(25)各自表示的化合物。(wherein y is an integer of 2 to 12, and z is an integer of 1 to 5). Among them, preferred are p-phenylenediamine, 4,4'-diaminobenzophenone diaminodiphenyl sulfide, 1,5-diaminonaphthalene, 2,7-diaminopurine, 4, Diphenyl ether, 2,2-bis[4-(4-aminophenoxy)phenyl]propane, 9-aminophenyl)anthracene, 2,2-di[4-(4-aminobenzene) Oxy)phenyl]hexafluoropropane, 4,4,-4,-diamine, 9-bis(4-alkane, 2,2--21-200907513 bis(4-aminophenyl)hexafluoropropane, 4,4'-(p-phenylenediisopropylidene)diphenylamine, 4,4'-(meta-phenyldiisopropylidene)diphenylamine, 1,4-cyclohexanediamine, 4, 4'-methylenebis(cyclohexylamine), 1,4-bis(4-aminophenoxy)benzene, 4,4'-bis(4-aminophenoxy)biphenyl, the above formula ( 10) to (14) each represented by a compound, 2,6-diaminopyridine, 3,4-diaminopyridine, 2,4-diaminopyrimidine, 3,6-diaminoacridine, and the above formula Among the compounds represented by the following formula (15), the compound represented by the following formula (16) and the compound represented by the above formula (V) in the compound represented by the above formula (IV); Compounds represented by formulas (17) to (25) .

-22- (15)200907513-22- (15)200907513

(17)(17)

-23- 200907513 〆.-23- 200907513 〆.

(22)(twenty two)

<聚醯胺酸的合成> -24- 200907513 供給聚醯胺酸合成反應的四羧酸二酐與二胺的使用比 例,較佳爲相對於1當量二胺的胺基,使四羧酸二酐的酸 酐基爲〇.5~2當量的比例’更佳爲使其爲0.74.2當量的比 例。 聚醯胺酸的合成反應’在有機溶劑中,較佳爲於 -2 0 t ~ 1 5 0 °C、更佳爲於〇〜1 〇 〇 °C的溫度條件下進行。 這裏,作爲有機溶劑,只要能夠溶解合成的聚醯胺酸 ,則對其沒有特別的限製,可以例示例如1 -甲基-2-吡咯烷 酮、Ν,Ν-二甲基乙醯胺、N,N-二甲基甲醯胺、3_丁氧基-N,N-二甲基丙醯胺、3-甲氧基-N,N-二甲基丙醯胺、3-己氧基 -N,N-二甲基丙醯胺等醯胺類溶劑、二甲基亞颯、γ-丁內酯 、四甲基脲、六甲基磷醯三胺等非質子系極性溶劑;間甲 基酚、二甲苯酚、苯酚、鹵代苯酚等酚類溶劑。此外,有 機溶劑的用量(〇0通常較佳爲使四羧酸二酐和二胺化合物 的總量(β)相對於反應溶液的總量(α+ β)爲0·1〜30重量%的 量。 另外,上述有機溶劑中,在不使生成的聚醯胺酸析出 的範圍內’還可以倂用聚醯胺酸的不良溶劑(P0〇r solvent) 醇類、酮類、酯類、醚類、鹵代烴類、烴類等。作爲這種 不良溶劑的具體例子,可以舉出例如甲醇、乙醇、異丙醇 、環己醇、4-羥基-4-甲基-2-戊酮、乙二醇、丙二醇、1,4-丁二醇、三甘醇、乙二醇單甲基醚、乳酸乙'醋、乳酸丁酯 、丙酮、甲基乙基酮、甲基異丁基酮、環己酮、醋酸甲酯 、醋酸乙酯、醋酸丁酯、甲氧基丙酸甲酯、乙氧基丙酸乙 -25- 200907513 基、酯、基氯、 甲醚酸醚乙二烷 醇基乙基單4-, 辛 二丙醚甲醇 1 、 乙異基單甘、院 ' 醇乙醇二院庚 醚二醇甘、U、 基乙二二酯-«院 乙'乙、酸-'~~己 二醚、醚乙1,2、 、 基醚基醚'1苯 酯丙基乙基院氯 乙正甲二 甲甲二 二醇二醇單氯鄰 酸二醇甘醇一一 、 二乙二二甘、苯 丙、乙、 二喃氯 、 醚、醚、呋、 酯基醚基醚氫烷 乙乙基甲基四乙 二醇 丁二乙、氯 酸二正醇單酯三 草乙醇甘醇酸 、 、 '二二甘乙烷 酯醚乙、二醚丁 本、甲苯、二甲苯、丙酸異戊酯、異丁酸異戊酯、二異戊 基醚等。 如上得到溶解了聚醯胺酸的反應溶液。然後,將該反 應溶液投入到大量的不良溶劑中,得到析出物,通過減壓 下乾燥該析出物,或者將反應溶液用蒸發器減壓蒸餾,可 得聚醯胺酸。並且,通過進行一次或者幾次使該聚醯胺酸 再次溶解於有機溶劑中,然後用不良溶劑使其析出的製程 ,或用蒸發器減壓蒸餾反應溶液的製程,可以精製聚醯胺 酸。 <脫水閉環反應> 構成本發明液晶配向劑的聚酿亞胺可以通過使具有上 述式(A)表示的重複單元的聚醯胺酸部分或全部脫水閉環 而合成。本發明中所使用的聚醯亞胺,其全部重複單元中 具有醯亞胺環的重複單元的比例(以下,也稱爲“醯亞胺化 率”)較佳爲40莫耳%以上,更佳爲50莫耳%以上。通過使 用醯亞胺化率爲4 0莫耳%以上的聚合物,可以獲得能夠形 成殘像消除時間短的液晶配向膜的液晶配向劑。 -26 - 200907513 聚醯胺酸的脫水閉環可以(i)通過加熱聚醯胺酸的方法 ,或者(Π)通過將聚醯胺酸溶解於有機溶劑中,向該溶液中 加入脫水劑和脫水閉環催化劑並根據需要加熱的方法而進 行。 上述(i)的加熱聚醯胺酸的方法的反應溫度,較佳爲 50〜200°C,更佳爲60〜170°C。當反應溫度不足50°C時,則 脫水閉環反應不能進行充分,若反應溫度超過20(TC,則 會出現所得醯亞胺化聚合物的分子量下降的情況。 另一方面,在上述(Π)的在聚醯胺酸溶液中添加脫水劑 和脫水閉環催化劑的方法中,作爲脫水劑,可以使用例如 醋酸酐、丙酸酐、三氟乙酸酐等酸酐。脫水劑的用量根據 所需的醯亞胺化率而定,較佳爲相對於1莫耳聚醯胺酸的 重複單元,爲〇』1〜20莫耳。另外,作爲脫水閉環催化劑 ,可以使用例如吡啶、三甲基吡啶、二甲基吡啶、三乙基 胺等3級胺。但是,並不局限於這些。脫水閉環催化劑的 用量,相對於1莫耳所用脫水劑,較佳爲0.01 ~ 1 0莫耳。 上述脫水劑、脫水閉環催化劑的用量越多,則可使醯亞胺 化率越高。另外,作爲脫水閉環反應中所用的有機溶劑, 可以舉出作爲聚醯胺酸合成中所用溶劑而例示的有機溶劑 。並且,脫水閉環反應的反應溫度,較佳爲0〜180°c ,更 佳爲1 0〜1 5 (TC。此外,通過對如此得到的反應溶液進行與 聚醯胺酸精製方法同樣的操作,可以精製所得聚醯亞胺。 <末端修飾型的聚合物> 本發明中所用的聚醯胺酸和聚醯亞胺還可以是進行了 -27- 200907513 分子量調節的末端修飾型聚合物。通過使用該 的聚合物’可以在不損害本發明效果的前提下 向劑的塗敷特性等。這種末端修飾型聚合物可 醯胺酸的合成時,向反應體系中加入一元酸酐 物、單異氰酸酯化合物等而合成。這裏,作爲 可以舉出例如馬來酸酐、苯二甲酸酐、衣康酸 琥珀酸酐、正十二烷基琥珀酸酐、正十四烷基 正十六烷基琥珀酸酐等。另外,作爲單胺化合 出例如苯胺、環己胺、正丁胺、正戊胺、正己 、正辛胺、正壬胺、正癸胺、正十一烷胺、正 正十三烷胺、正十四烷胺、正十五烷胺、正十 十七烷胺、正十八烷胺、正二十烷胺等。另外 氰酸酯化合物,可以舉出例如異氰酸苯酯、異 等。 [聚合物的溶液黏度] 如上製得的聚醯胺酸和聚醯亞胺’各自較 10%的溶液時,具有20〜800 mPa‘s的黏度’ 30〜500 mPa.s的黏度。 另外,聚合物的溶液黏度(m P a · s)是採用規 對固體成分濃度稀釋爲10 %的溶液採用E型旋 2 5 °C下測定的。 [液晶配向劑] 本發明的液晶配向劑通常是將上述聚醯胺 胺溶解含於有機溶劑中而構成的。 末端修飾型 改善液晶配 以通過在聚 、單胺化合 一元酸酐, 酐、正癸基 琥珀酸酐、 物,可以舉 胺、正庚胺 十二烷胺、 六烷胺、正 ,作爲單異 氰酸萘基酯 佳爲當配成 更佳爲具有 定的溶劑’ 轉黏度計在 酸和聚醯亞 -28- 200907513 調製本發明液晶配向劑時的溫度,較佳爲〜2〇(rc ,更佳爲20°C〜60°C。 作爲構成本發明液晶配向劑的有機溶劑,可以舉出作 爲特定聚醯胺酸合成反應中所用的溶劑而例示的溶劑。另 外’還可以適當地選擇倂用作爲特定聚醯胺酸的合成反應 中可倂用的而例示的不良溶劑。 作爲本發明液晶配向劑中使用的特佳的有機溶劑,可 以舉出例如1-甲基-2-Π比咯院酮、γ -丁內醋、γ_ 丁內酿胺、 Ν,Ν-二甲基甲醯胺、Ν,Ν-二甲基乙醯胺、4-羥基_4_甲基_2_ 戊酮、乙二醇單甲基醚、乳酸丁酯、乙酸丁酯、甲氧基丙 酸甲酯、乙氧基丙酸乙酯、乙二醇甲基醚、乙二醇乙基醚 、乙二醇正丙基醚、乙二醇異丙基醚、乙二醇正丁基醚(丁 基溶纖劑)、乙二醇二甲基醚、乙二醇乙基醚乙酸酯、二甘 醇二甲基醚、二甘醇二乙基醚、二甘醇單甲基醚、二甘醇 單乙基醚、二甘醇單甲基醚乙酸酯、二甘醇單乙基醚乙酸 酯、3 -丁氧基- Ν,Ν -二甲基丙醯胺、3 -甲氧基- Ν,Ν -二甲基丙 醯胺、3-己基氧基-Ν,Ν-二甲基丙醯胺、二乙基卡必醇、乙 基卡必醇乙酸酯、丁基卡必醇、三甘醇二甲基醚、異丁酸 異戊酯、二異戊基醚等。其中3-丁氧基- Ν,Ν-二甲基丙醯胺 、3-甲氧基-Ν,Ν-二甲基丙醯胺、3-己基氧基-Ν,Ν-二甲基丙 醯胺由於表現出良好的印刷性而特佳。 本發明液晶配向劑中固體成分濃度考慮黏性、揮發性 等而進行選擇,較佳爲1~10重量%的範圍。換句話說,將 本發明液晶配向劑塗敷於基板表面’形成作爲液晶配向膜 -29- 200907513 的塗膜,當固體成分濃度不足1重量%時,將導致該塗膜 的厚度過小,從而不能獲得良好的液晶配向膜;當固體成 分濃度超過10重量%時,將導致塗膜厚度過厚,從而不能 獲得良好的液晶配向膜,並且,液晶配向劑的黏性增大, 導致塗敷特性變差。 本發明的液晶配向劑中,在不損害目的物性的範圍內 ,從使其提高對基板表面的接著性的角度出發,還可以包 括含官能性矽烷的化合物、環氧基化合物。作爲這種含官 能性矽烷的化合物,可以舉出例如3 -胺基丙/基三甲氧基矽 烷、3-胺基丙基三乙氧基矽烷、2-胺基丙基三甲氧基矽烷 、2·胺基丙基三乙氧基矽烷、N-(2-胺基乙基)-3-胺基丙基 三甲氧基矽烷、N-(2-胺基乙基)-3-胺基丙基甲基二甲氧基 矽烷、3-脲基丙基三甲氧基矽烷、3-脲基丙基三乙氧基矽 烷、N-乙氧羰基-3-胺基丙基三甲氧基矽烷、N-乙氧羰基- 3-胺基丙基三乙氧基矽烷、N-三乙氧基矽烷基丙基三伸乙基 三胺、N-三甲氧基矽烷基丙基三伸乙基三胺、10-三甲氧基 矽烷基-1,4,7-三氮雜癸烷、10-三乙氧基矽烷基-1,4,7-三氮 雜癸烷、9-三甲氧基矽烷基-3,6-二氮雜壬基乙酸酯、9-三 乙氧基矽烷基-3,6-二氮雜壬基乙酸酯、N-苄基-3-胺基丙基 三甲氧基矽烷、N-苄基-3-胺基丙基三乙氧基矽烷、N-苯基 -3-胺基丙基三甲氧基矽烷、N-苯基-3-胺基丙基三乙氧基矽 烷、N-二(氧乙烯基)·3-胺基丙基三甲氧基矽烷、N-二(氧乙 烯基)-3-胺基丙基三乙氧基矽烷等。這些其他含官能性矽烷 的化合物的混合比例,相對於1 0 0重量份聚合物之合計量 -30- 200907513 ’較佳爲10重量份以下,更佳爲〇.01〜5重量份。 作爲這種環氧基化合物,可以舉出例如乙二醇二縮水 甘油醚、聚乙二醇二縮水甘油醚、丙二醇二縮水甘油醚、 三丙二醇二縮水甘油醚、聚丙二醇二縮水甘油醚、新戊二 醇二縮水甘油醚、1,6 -己二醇二縮水甘油醚、甘油二縮水 甘油醚、2,2-二溴新戊二醇二縮水甘油醚、1,3,5,6-四縮水 甘油基- 2,4-己二醇、N,N,N’,N’-四縮水甘油基-間苯二甲胺 、:1,3-二(N,N-二縮水甘油基胺基甲基)環己烷、:N,N,N’,N’- 四縮水甘油基-4,4’-二胺基二苯基甲烷、3-(N-烯丙基-N-縮 水甘油基)胺基丙基三甲氧基矽烷、3-(N,N-二縮水甘油基) 胺基丙基三甲氧基矽烷等。並且’作爲含環氧基化合物’ 較佳的可以舉出例如乙二醇二縮水甘油醚、聚乙二醇二縮 水甘油醚、丙二醇二縮水甘油酸、三丙二醇二縮水甘油醚 、聚丙二醇二縮水甘油酸、新戊一醇一縮水甘油釀、1,6- 己一醇二縮水甘油酸、甘油一縮水甘油醚、2,2 - 一·溴新戊 二醇二縮水甘油酸、丨,3,5,6-四縮水甘油基-2,4-己二醇、 N,N,N,,N,_四縮水甘油基-間苯二甲胺、丨,3·二(N,N-二縮水 甘油基胺基甲基)環己烷、N,N,N’,N’-四縮水甘油基-4,4’- 一胺基—苯基甲烷、N,N,N,,N,-四縮水甘油基_4,4’·二胺基 一*甘_ 1 4-二(N,N-二縮水甘油基胺基甲基)環己烷、 一本基腿、’ 1 3.二(N N-二縮水甘油基胺基甲基)苯、丨,4-二(N,N_二縮水 甘油基胺基甲基)苯、3-(N-烯丙基-N-縮水甘油基)胺基丙基 一 访桉、3-(N,N- =縮水甘油基)胺基丙基三甲氧基矽 三甲氧基砂抓 一給水甘油基-苄基胺、Ν,Ν·二縮水甘油基_胺基 烷、Ν,Ν-—削日 -31 - 200907513 甲基環己烷等。這些縮水甘油基胺基類含環氧基化合物的 混合比例,相對於1 0 0重量份聚合物’較佳爲5 0重量份以 下,更佳爲0.1〜40重量份,更佳爲〇·〇1〜5重量份。 <液晶顯示元件> 採用本發明液晶配向劑製得的液晶顯示元件可以通過 例如以下的方法製造。 (1)通過平版印刷法、旋塗法或者噴墨印刷法,將本發 明的液晶配向劑塗敷在設有形成圖案的透明導電膜的基板 的一面上,接著,通過對塗敷面進行加熱形成塗膜。這裏 ,作爲基板,可以使用例如浮法玻璃、鈉鈣玻璃等玻璃; 由聚對苯二甲酸乙二醇酯、聚對苯二甲酸丁二醇酯、聚醚 砸、聚碳酸酯等塑膠所構成之透明基板。作爲基板一面上 所設置的透明導電膜,可以使用由氧化錫(Sn02)所構成的 NESA膜(美國 PPG公司註冊商標)、由氧化銦一氧化錫 (Ιη203 — Sn02)所構成的ITO膜等。這些透明導電膜的形成 圖案採用光蝕刻法或者預先使用遮罩的方法。在液晶配向 劑的塗敷時,爲了進一步改善基板表面和透明導電膜與塗 膜的接著性,還可以在基板的該表面上預先塗敷含官能性 矽烷的化合物、含官能性鈦的化合物等。液晶配向劑塗敷 後的加熱溫度較佳爲80〜3 00°C,更佳爲120〜25 0°C。含有 聚醯胺酸的本發明液晶配向劑,通過塗敷後除去有機溶劑 ,形成作爲配向膜的塗膜,其還可以進一步通過加熱進行 脫水閉環,以形成進一步醯亞胺化的塗膜。形成的塗膜的 厚度爲例如0.001〜Ιμιη,較佳爲0.005〜0.5μιη。 -32- 200907513 (2) 採用纏有由例如尼龍、人造纖維、棉花等纖維所構 成的布的輥對形成的塗膜面進行以一定方向摩擦的打磨 (rubbing)處理。這樣,使塗膜上產生液晶分子配向能,製 成液晶配向膜。另外,通過對由本發明液晶配向劑形成的 液晶配向膜,進行例如日本特開平6— 222366號公報或曰 本特開平6 — 2 8 1 9 3 7號公報中所示的、部分照射紫外線而 使預傾角改變的處理,或者進行日本特開平5 - 1 0 7 5 4 4號 公報中所示的、在實施打磨處理的液晶配向膜表面上部分 地形成保護膜’以與先前打磨處理不同的方向進行打磨處 理後’除去保護膜,使液晶配向膜的液晶配向能改變的處 理,能夠改善液晶顯示元件的視野特性。 (3) 製作2片如上形成液晶配向膜的基板,將2片基板 通過間隙(晶胞間隙)相對放置,使各自液晶配向膜的打磨 方向相互垂直或逆平行,將2片基板周邊部位用密封劑貼 合,向由基板表面和密封劑分割出的晶胞間隙內注入塡充 液晶’封閉注入孔’構成液晶胞。然後,在液晶胞的外表 面’即構成液晶胞的各基板的另一側面上,貼合偏光板, 使其偏光方向與該基板一面上所形成的液晶配向膜的打磨 方向一致或垂直,製得液晶顯示元件。 這裏,作爲密封劑,可以使用例如作爲硬化劑和間隙 物的含氧化鋁球的環氧樹脂等。 作爲液晶,可以舉出向列型液晶和層列型液晶,其中 較佳爲向列型液晶,可以使用例如希夫氏鹼類液晶、氧化 偶氮基類液晶、聯苯類液晶、苯基環己烷類液晶、酯類液 -33- 200907513 晶、三聯苯類液晶、聯苯基環己烷類液晶、嘧啶類液晶、 二噚烷類液晶、雙環辛烷類液晶、立方烷類液晶等。此外 ,這些液晶中還可以添加例如氯化膽固醇、膽固醇壬酸酯 、膽固醇碳酸酯等膽固型液晶和以商品名“C-15”、“CB-15”( 默克公司製)銷售的手性劑等而進行使用。並且,還可以使 用對癸氧基苯亞甲基-對胺基-2-甲基丁基肉桂酸酯等鐵電 性液晶。 另外,作爲液晶胞外表面上貼合的偏光板,可以舉出 將聚乙烯醇延伸配向同時吸收碘所得的、稱作爲Η膜的偏 光膜夾在醋酸纖維保護膜中而製成的偏光板或者由Η膜自 身所構成的偏光板。 以下,通過實施例對本發明進行更具體的說明,但是 本發明並不局限於這些實施例。 [印刷性評價] 預先製備在一側整面上形成了 ΙΤΟ 膜的 127mm(D)xl27mm(W)xl.lmm(H)玻璃基板,採用液晶配向 膜塗敷用印刷機(日本照相印刷(股)製造,Angstromer S — 40L),將上述實驗中製得的液晶配向劑在用孔徑爲0.2μιη 的微孔濾器過濾後,塗敷於該玻璃基板的透明電極面上。 採用設定爲80°C的加熱板密著式預乾燥機進行乾燥,再在 200 °C下烘烤10分鐘,從而在帶有ITO膜的玻璃基板上形 成液晶配向膜。目測評價所得配向膜的不勻,沒有不勻的 判斷爲“〇”,發現不勻的判斷爲“X”。 [電壓保持率] -34- 200907513 在1 67毫秒的時間間隔內,對液晶顯示元件施加5V 的電壓’電壓施加時間爲60微秒,然後測定從電壓解除至 1 67毫秒後的電壓保持率。測定裝置採用東陽科技(股)製造 的 VHR- 1 〇 [殘影試驗] 製作具有如第1圖所示的ITO電極的晶胞。在室溫下 向電極A施加2 4小時6.0 V的直流電壓,向電極B施加2 4 小時0.5 V的直流電壓。釋放應力後,向電極A和B分別 以0 · 1 V的增幅施加〇 . 1〜5.0 V直流電壓,通過各電壓下電 極A與B的亮度差判斷殘影特性。當亮度差大時,殘影特 性判斷爲差。沒有發現殘影的記爲◦,發生較弱殘影的記 爲△,發生較強殘影的記爲X。 合成例1 以下的反應在氮氣環境下按照下述流程進行。<Synthesis of polyglycolic acid> -24- 200907513 The ratio of use of the tetracarboxylic dianhydride to the diamine supplied to the polyamido acid synthesis reaction is preferably a tetracarboxylic acid with respect to 1 equivalent of the amine group of the diamine The acid anhydride group of the acid dianhydride is in a ratio of ~. 5 to 2 equivalents, more preferably in a ratio of 0.74.2 equivalents. The synthesis reaction of polylysine is carried out in an organic solvent, preferably at a temperature of from -2 0 t to 150 ° C, more preferably at a temperature of from 〇1 to 1 °C. Here, the organic solvent is not particularly limited as long as it can dissolve the synthesized polyaminic acid, and examples thereof include 1-methyl-2-pyrrolidone, hydrazine, hydrazine-dimethylacetamide, and N, N. - dimethylformamide, 3-butoxy-N,N-dimethylpropanamide, 3-methoxy-N,N-dimethylpropanamide, 3-hexyloxy-N, An aprotic solvent such as a guanamine solvent such as N-dimethylpropionamide; an aprotic polar solvent such as dimethyl hydrazine, γ-butyrolactone, tetramethyl urea or hexamethylphosphonium triamine; m-methylphenol; a phenolic solvent such as xylenol, phenol or halogenated phenol. Further, the amount of the organic solvent (〇0 is usually preferably such that the total amount (β) of the tetracarboxylic dianhydride and the diamine compound is from 0.1 to 30% by weight based on the total amount of the reaction solution (α + β). Further, in the above organic solvent, a poor solvent of polyglycolic acid (P0〇r solvent), an alcohol, a ketone, an ester, or an ether may be used in a range in which the produced polyaminic acid is not precipitated. Examples, halogenated hydrocarbons, hydrocarbons, etc. Specific examples of such a poor solvent include methanol, ethanol, isopropanol, cyclohexanol, and 4-hydroxy-4-methyl-2-pentanone. Ethylene glycol, propylene glycol, 1,4-butanediol, triethylene glycol, ethylene glycol monomethyl ether, lactated B' vinegar, butyl lactate, acetone, methyl ethyl ketone, methyl isobutyl ketone, Cyclohexanone, methyl acetate, ethyl acetate, butyl acetate, methyl methoxypropionate, ethoxypropyl propionate B-25-200907513 base, ester, chloro, methyl ether ether ethanediyl alcohol Ethyl mono 4-, octyl dipropyl ether methanol 1, Ethyl mono-monoethylene, hospital 'Alcohol Ethanol second-half-heptane glycol diol, U, base ethylene di-diester - «院乙' B, acid-'~~ Dihexyl ether, ether B 1,2, phenyl ether ether '1 phenyl ester propyl ethyl chlorodimethyl dimethyl diol di diol diol monochloro acid glycol glycerol one, two ethane diethylene glycol, styrene , B, dimethyl chloride, ether, ether, fur, ester ether ether ether hydroperyl ethyl ethyl methyl tetraethylene glycol butyl dichloride, di-n-alcohol monoester octane ethanol glycolic acid, 'two Diethylene glycol ester ether B, diether butyl, toluene, xylene, isoamyl propionate, isoamyl isobutyrate, diisoamyl ether, etc. The reaction solution in which polylysine is dissolved is obtained as above. Then, the reaction solution is poured into a large amount of a poor solvent to obtain a precipitate, and the precipitate is dried by a reduced pressure, or the reaction solution is distilled under reduced pressure with an evaporator to obtain a polyamic acid. Alternatively, the poly-proline may be purified by re-dissolving the poly-proline in an organic solvent, and then using a poor solvent to precipitate the solution, or by distilling the reaction solution under reduced pressure with an evaporator. > The stylimine constituting the liquid crystal alignment agent of the present invention can have the above formula ( The polyaminone group of the repeating unit represented by A) is partially or completely dehydrated and closed. The polyimine used in the present invention has a ratio of repeating units having a quinone ring in all repeating units (hereinafter, also referred to as The "yttrium imidation ratio" is preferably 40 mol% or more, more preferably 50 mol% or more. By using a polymer having a ruthenium iodide ratio of 40 mol% or more, it is possible to form a residue. A liquid crystal alignment agent such as a liquid crystal alignment film having a short elimination time. -26 - 200907513 The dehydration ring closure of polylysine can be (i) by heating poly-proline, or (Π) by dissolving poly-lysine in organic In the solvent, a dehydrating agent and a dehydration ring-closure catalyst are added to the solution and heated as needed. The reaction temperature of the above method (i) for heating the polyamic acid is preferably 50 to 200 ° C, more preferably 60 to 170 ° C. When the reaction temperature is less than 50 ° C, the dehydration ring-closure reaction cannot be sufficiently carried out. If the reaction temperature exceeds 20 (TC, the molecular weight of the obtained ruthenium-imided polymer may decrease. On the other hand, in the above (Π) In the method of adding a dehydrating agent and a dehydration ring-closing catalyst to a polyamic acid solution, as the dehydrating agent, an acid anhydride such as acetic anhydride, propionic anhydride or trifluoroacetic anhydride can be used. The amount of the dehydrating agent depends on the desired quinone imine. The amount of the repeating unit relative to 1 mole of polyamic acid is preferably from 1 to 20 moles. Further, as the dehydration ring-closing catalyst, for example, pyridine, trimethylpyridine or dimethyl group can be used. A tertiary amine such as pyridine or triethylamine. However, it is not limited thereto. The amount of the dehydration ring-closing catalyst is preferably 0.01 to 10 moles per mol of the dehydrating agent used. The more the amount of the catalyst used, the higher the yield of ruthenium. The organic solvent used in the dehydration ring closure reaction is exemplified as the solvent used in the synthesis of polylysine. Further, the reaction temperature of the dehydration ring-closure reaction is preferably from 0 to 180 ° C, more preferably from 10 to 15 (TC. Further, the same reaction as the polyamic acid purification method is carried out on the reaction solution thus obtained. The obtained polyimine can be purified. <End-modified polymer> The poly-proline and polyimine used in the present invention may also be a terminal-modified polymer having a molecular weight adjusted from -27 to 200907513. By using the polymer ', it is possible to impart coating characteristics to the agent without impairing the effects of the present invention. When the terminal-modified polymer is capable of synthesizing proline, a monobasic acid anhydride is added to the reaction system, The monoisocyanate compound or the like is synthesized, and examples thereof include maleic anhydride, phthalic anhydride, itaconic acid succinic anhydride, n-dodecyl succinic anhydride, n-tetradecyl n-hexadecyl succinic anhydride, and the like. Further, as a monoamine, for example, aniline, cyclohexylamine, n-butylamine, n-pentylamine, n-hexyl, n-octylamine, n-decylamine, n-decylamine, n-undecylamine, n-tridecylamine, N-tetradecylamine, Zhengshi The alkylamine, n-heptadecaneamine, n-octadecylamine, n-icosylamine, etc. Further, the cyanate compound may, for example, be phenyl isocyanate or the like. [Solid viscosity of the polymer] When the polylysine and polyimine prepared above have a 10% solution, the viscosity has a viscosity of 30 to 800 mPa's of 30 to 500 mPa.s. In addition, the solution viscosity of the polymer (m P a · s) is a solution diluted to a solid component concentration of 10% by E-type rotation at 25 ° C. [Liquid crystal alignment agent] The liquid crystal alignment agent of the present invention is usually prepared by dissolving the above polyamine amine. It is composed of an organic solvent. The terminal modified type improves the liquid crystal by using a mono-anhydride in a poly-monoamine, an anhydride, an n-decyl succinic anhydride, and an amine, n-heptylamine dodecylamine, hexadecaneamine. , positive, as the monoisocyanato naphthyl ester is preferably formulated to have a constant solvent, the viscosity of the liquid crystal alignment agent is preferably adjusted in the acid and polyphthalocyanine-28-200907513, preferably ~ 2 〇 (rc, more preferably 20 ° C ~ 60 ° C. The organic solvent constituting the liquid crystal alignment agent of the present invention may, for example, be a solvent exemplified as a solvent used in the specific polyamine acid synthesis reaction. Further, it is also possible to appropriately select a poor solvent which is exemplified as a useful one in the synthesis reaction of a specific polyamine. The particularly preferable organic solvent to be used in the liquid crystal alignment agent of the present invention may, for example, be 1-methyl-2-pyridyl ketone, γ-butane vinegar, γ-butene amide, hydrazine, hydrazine-dimethyl methacrylate. Mercaptoamine, hydrazine, hydrazine-dimethylacetamide, 4-hydroxy-4-methyl-2-pentanone, ethylene glycol monomethyl ether, butyl lactate, butyl acetate, methoxypropionic acid Methyl ester, ethyl ethoxypropionate, ethylene glycol methyl ether, ethylene glycol ethyl ether, ethylene glycol propyl ether, ethylene glycol isopropyl ether, ethylene glycol n-butyl ether (butyl cellosolve ), ethylene glycol dimethyl ether, ethylene glycol ethyl ether acetate, diethylene glycol dimethyl ether, diethylene glycol diethyl ether, diethylene glycol monomethyl ether, diethylene glycol monoethyl Ether, diethylene glycol monomethyl ether acetate, diethylene glycol monoethyl ether acetate, 3-butoxy-hydrazine, hydrazine-dimethylpropionamide, 3-methoxy-hydrazine, hydrazine - dimethylpropanamide, 3-hexyloxy-oxime, guanidine-dimethylpropionamine, diethyl carbitol, ethyl carbitol acetate, butyl carbitol, triethylene glycol Dimethyl ether, isoamyl isobutyrate, diisoamyl ether, and the like. Wherein 3-butoxy-indole, hydrazine-dimethylpropanamide, 3-methoxy-indole, hydrazine-dimethylpropanamide, 3-hexyloxy-oxime, hydrazine-dimethylpropionamidine The amine is particularly excellent in that it exhibits good printability. The solid content concentration in the liquid crystal alignment agent of the present invention is selected in consideration of viscosity, volatility, etc., and is preferably in the range of 1 to 10% by weight. In other words, the liquid crystal alignment agent of the present invention is applied to the surface of the substrate to form a coating film as the liquid crystal alignment film -29-200907513. When the solid content concentration is less than 1% by weight, the thickness of the coating film is too small, so that A good liquid crystal alignment film is obtained; when the solid content concentration exceeds 10% by weight, the thickness of the coating film is too thick, so that a good liquid crystal alignment film cannot be obtained, and the viscosity of the liquid crystal alignment agent is increased, resulting in a change in coating characteristics. difference. In the liquid crystal alignment agent of the present invention, a functional decane-containing compound or an epoxy compound may be included from the viewpoint of improving the adhesion to the surface of the substrate within a range not impairing the physical properties of the object. As such a functional decane-containing compound, for example, 3-aminopropyl/yltrimethoxydecane, 3-aminopropyltriethoxydecane, 2-aminopropyltrimethoxydecane, 2 Aminopropyltriethoxydecane, N-(2-aminoethyl)-3-aminopropyltrimethoxydecane, N-(2-aminoethyl)-3-aminopropyl Methyldimethoxydecane, 3-ureidopropyltrimethoxydecane, 3-ureidopropyltriethoxydecane, N-ethoxycarbonyl-3-aminopropyltrimethoxydecane, N- Ethoxycarbonyl-3-aminopropyltriethoxydecane, N-triethoxydecylpropyltriethylethylamine, N-trimethoxydecylpropyltriethylamine, 10 -trimethoxydecyl-1,4,7-triazadecane, 10-triethoxydecyl-1,4,7-triazadecane, 9-trimethoxydecyl-3 6-diazaindolyl acetate, 9-triethoxydecyl-3,6-diazaindolyl acetate, N-benzyl-3-aminopropyltrimethoxydecane, N -benzyl-3-aminopropyltriethoxydecane, N-phenyl-3-aminopropyltrimethoxydecane, N-phenyl-3-aminopropyltriethoxydecane, N -two Oxyethylene) - 3-amino propyl trimethoxy Silane, N- bis (oxyethylene) -3-aminopropyl triethoxy silane-like. The mixing ratio of these other functional decane-containing compounds is preferably 10 parts by weight or less, more preferably 0.001 to 5 parts by weight, based on 100 parts by weight of the total amount of the polymer. Examples of such an epoxy compound include ethylene glycol diglycidyl ether, polyethylene glycol diglycidyl ether, propylene glycol diglycidyl ether, tripropylene glycol diglycidyl ether, polypropylene glycol diglycidyl ether, and new Pentyl glycol diglycidyl ether, 1,6-hexanediol diglycidyl ether, glycerol diglycidyl ether, 2,2-dibromoneopentyl glycol diglycidyl ether, 1,3,5,6-four Glycidyl- 2,4-hexanediol, N,N,N',N'-tetraglycidyl-m-xylylenediamine, :1,3-di(N,N-diglycidylamino) Methyl)cyclohexane, :N,N,N',N'-tetraglycidyl-4,4'-diaminodiphenylmethane, 3-(N-allyl-N-glycidyl Aminopropyltrimethoxydecane, 3-(N,N-diglycidyl)aminopropyltrimethoxydecane, and the like. Further, as the epoxy group-containing compound, for example, ethylene glycol diglycidyl ether, polyethylene glycol diglycidyl ether, propylene glycol diglycidyl acid, tripropylene glycol diglycidyl ether, and polypropylene glycol dihydrate may be mentioned. Glyceric acid, neopentyl alcohol-glycidol, 1,6-hexanol diglycidyl acid, glycerol monoglycidyl ether, 2,2- bromopentyl glycol diglycidyl acid, hydrazine, 3, 5,6-tetraglycidyl-2,4-hexanediol, N,N,N,,N,_tetraglycidyl-m-xylylenediamine, anthracene, 3·2 (N,N-bi-diverted water) Glycerylaminomethyl)cyclohexane, N,N,N',N'-tetraglycidyl-4,4'-monoamino-phenylmethane, N,N,N,,N,-four Glycidyl _4,4'·diamino-mono-gly- 1 4-di(N,N-diglycidylaminomethyl)cyclohexane, one base leg, '1 3. two (N N-diglycidylaminomethyl)benzene, anthracene, 4-bis(N,N-diglycidylaminomethyl)benzene, 3-(N-allyl-N-glycidyl)amine Propyl-indole, 3-(N,N-=glycidyl)aminopropyltrimethoxyfluorene A water supply methoxy sand caught glyceryl - benzylamine, Ν, Ν · _ diglycidyl amino alkyl, Ν, Ν-- cut day -31--200907513 methylcyclohexane. The mixing ratio of the glycidylamino group-containing epoxy group-containing compound is preferably 50 parts by weight or less, more preferably 0.1 to 40 parts by weight, more preferably 〇·〇 with respect to 100 parts by weight of the polymer. 1 to 5 parts by weight. <Liquid crystal display element> The liquid crystal display element obtained by using the liquid crystal alignment agent of the present invention can be produced, for example, by the following method. (1) The liquid crystal alignment agent of the present invention is applied onto one surface of a substrate provided with a patterned transparent conductive film by a lithography method, a spin coating method or an inkjet printing method, followed by heating the coated surface A coating film is formed. Here, as the substrate, for example, glass such as float glass or soda lime glass can be used; and it is composed of plastic such as polyethylene terephthalate, polybutylene terephthalate, polyether oxime or polycarbonate. Transparent substrate. As the transparent conductive film provided on one surface of the substrate, an NESA film made of tin oxide (Sn02) (registered trademark of PPG Corporation of the United States), an ITO film made of indium tin oxide (Mn 203-Sn02), or the like can be used. The pattern of formation of these transparent conductive films is a photolithography method or a method in which a mask is used in advance. In the application of the liquid crystal alignment agent, in order to further improve the adhesion between the surface of the substrate and the transparent conductive film and the coating film, a functional decane-containing compound, a functional titanium-containing compound, or the like may be applied to the surface of the substrate in advance. . The heating temperature after application of the liquid crystal alignment agent is preferably from 80 to 300 ° C, more preferably from 120 to 25 ° C. The liquid crystal alignment agent of the present invention containing polylysine is subjected to coating to remove an organic solvent to form a coating film as an alignment film, which may be further subjected to dehydration ring closure by heating to form a further imidized coating film. The thickness of the formed coating film is, for example, 0.001 to Ιμηη, preferably 0.005 to 0.5 μm. -32- 200907513 (2) A rubbing treatment in which a coating film formed by a pair of rolls composed of fibers such as nylon, rayon, cotton or the like is rubbed in a certain direction is rubbed. Thus, the alignment energy of the liquid crystal molecules is generated on the coating film to form a liquid crystal alignment film. In addition, the liquid crystal alignment film formed of the liquid crystal alignment agent of the present invention is partially irradiated with ultraviolet rays as shown in Japanese Laid-Open Patent Publication No. Hei 6-222366, or the Japanese Patent Publication No. Hei. The treatment of the pretilt angle change, or the partial formation of the protective film on the surface of the liquid crystal alignment film subjected to the rubbing treatment as shown in Japanese Laid-Open Patent Publication No. Hei No. 5 - 1 0 7 4 4, in a direction different from the previous polishing process After the polishing treatment, the protective film is removed, and the liquid crystal alignment of the liquid crystal alignment film can be changed, and the visual field characteristics of the liquid crystal display element can be improved. (3) Two substrates on which the liquid crystal alignment film is formed are formed, and the two substrates are placed opposite each other through a gap (cell gap) so that the polishing directions of the respective liquid crystal alignment films are perpendicular or antiparallel to each other, and the peripheral portions of the two substrates are sealed. The agent is bonded, and a liquid crystal cell is formed by injecting a liquid crystal 'closed injection hole' into the cell gap which is divided by the surface of the substrate and the sealant. Then, on the outer surface of the liquid crystal cell, that is, the other side surface of each of the substrates constituting the liquid crystal cell, the polarizing plate is bonded so that the polarizing direction thereof coincides with or perpendicular to the rubbing direction of the liquid crystal alignment film formed on one side of the substrate. A liquid crystal display element is obtained. Here, as the sealant, for example, an alumina ball-containing epoxy resin as a curing agent and a spacer may be used. Examples of the liquid crystal include a nematic liquid crystal and a smectic liquid crystal. Among them, a nematic liquid crystal is preferable, and for example, a Schiff base liquid crystal, an oxidized azo liquid crystal, a biphenyl liquid crystal, or a phenyl ring can be used. Hexane liquid crystal and ester liquid-33-200907513 Crystal, terphenyl liquid crystal, biphenylcyclohexane liquid crystal, pyrimidine liquid crystal, dioxane liquid crystal, bicyclooctane liquid crystal, cubic liquid crystal or the like. Further, in these liquid crystals, a bile-type liquid crystal such as chlorinated cholesterol, cholesterol phthalate or cholesterol carbonate, and a hand sold under the trade names "C-15" and "CB-15" (manufactured by Merck) may be added. It is used as a sex agent. Further, a ferroelectric liquid crystal such as p-methoxybenzylidene-p-amino-2-methylbutylcinnamate may also be used. In addition, the polarizing plate to be bonded to the outer surface of the liquid crystal may be a polarizing plate obtained by stretching a polyvinyl alcohol and absorbing iodine while absorbing iodine, and a polarizing film called a ruthenium film is sandwiched between the cellulose acetate protective film or A polarizing plate composed of the enamel film itself. Hereinafter, the present invention will be more specifically described by way of examples, but the invention is not limited to the examples. [Printability Evaluation] A 127 mm (D) x 27 mm (W) x l.lmm (H) glass substrate having a ruthenium film formed on one side of the entire surface was prepared in advance, and a liquid crystal alignment film coating printing machine was used (Japan Photo Printing Co., Ltd.) Manufactured, Angstromer S - 40L), the liquid crystal alignment agent prepared in the above experiment was filtered on a transparent electrode surface of the glass substrate after filtering with a micropore filter having a pore size of 0.2 μm. The film was dried by a hot plate preheater set at 80 ° C, and baked at 200 ° C for 10 minutes to form a liquid crystal alignment film on a glass substrate with an ITO film. The unevenness of the obtained alignment film was visually evaluated, and it was judged as "〇" without unevenness, and "X" was found to be uneven. [Voltage retention ratio] -34- 200907513 A voltage of 5 V was applied to the liquid crystal display element during the time interval of 67 ms. The voltage application time was 60 μsec, and then the voltage holding ratio from the voltage release to 167 ms was measured. In the measuring apparatus, VHR-1 〇 [Image Residual Test] manufactured by Toyo Technology Co., Ltd. was used to produce a unit cell having an ITO electrode as shown in Fig. 1. A DC voltage of 6.0 V was applied to the electrode A at room temperature for 24 hours, and a DC voltage of 0.5 V was applied to the electrode B for 24 hours. After the stress is released, 电极1 to 5.0 V DC voltage is applied to the electrodes A and B at an increment of 0·1 V, respectively, and the residual image characteristics are judged by the difference in luminance between the electrodes A and B at each voltage. When the luminance difference is large, the afterimage characteristic is judged to be poor. No residual image was found as ◦, a weak residual image was recorded as △, and a strong residual image was recorded as X. Synthesis Example 1 The following reaction was carried out in a nitrogen atmosphere according to the following scheme.

將 22g(0.2 mol)苯硫酚、31.2g(0.1 mol)4,4、二溴聯 苯、69.lg(〇.5 mol)碳酸鉀、500 ml DMF在安裝了迪姆羅 特式冷凝管的三頸燒瓶中混合。加熱至6 0 °C ’並攪拌8小 時。將反應溶液冷卻,將反應溶液加入到2 L 1 0 %的鹽酸水 溶液中。再加入N Η 4 P F 6 (〇 · 2 m ο 1),攪拌2小時。過濾析出 -35- 200907513 的固體,將固體依次用水、二乙基酸進行洗滌。再通過管 柱層析進行精製,得到2 7.8 g目標化合物1 (化合物A)。 合成例2 以下的反應在氮氣環境下按照下述流程進行。22g (0.2 mol) thiophenol, 31.2g (0.1 mol) 4,4, dibromobiphenyl, 69.lg (〇.5 mol) potassium carbonate, 500 ml DMF were installed in the Dimrod condenser Mix in a three-necked flask. Heat to 60 °C and stir for 8 hours. The reaction solution was cooled, and the reaction solution was added to 2 L of a 10% aqueous hydrochloric acid solution. Then add N Η 4 P F 6 (〇 · 2 m ο 1) and stir for 2 hours. The solid of -35-200907513 was filtered off, and the solid was washed successively with water and diethyl acid. Further purification by column chromatography gave 27.8 g of the title compound 1 (Compound A). Synthesis Example 2 The following reaction was carried out in a nitrogen atmosphere according to the following scheme.

將 31g(0.2 mol)對硝基苯硫酚、3128(0.1 m〇l)4,4’-二 溴聯苯、69.1g(0.5 mol)碳酸鉀、500 ml DMF在安裝了迪 姆羅特式冷凝管的三頸燒瓶中混合。加熱至60 °C,並攪拌 8小時。將反應溶液冷卻,將反應溶液加入到2 L 1 0 %的鹽 酸水溶液中。再加入32.6g(0.2 mol)NH4PF6’攪拌2小時。 過濾析出的固體,將固體依次用水、二乙基醚進行洗滌。 再通過管柱層析進行精製’得到32.2g目標化合物2。 合成例331g (0.2 mol) of p-nitrothiophenol, 3128 (0.1 m〇l) 4,4'-dibromobiphenyl, 69.1 g (0.5 mol) of potassium carbonate, 500 ml of DMF were installed in Dimrot The three-necked flask of the condenser was mixed. Heat to 60 ° C and stir for 8 hours. The reaction solution was cooled, and the reaction solution was added to 2 L of a 10% aqueous hydrochloric acid solution. Further, 32.6 g (0.2 mol) of NH4PF6' was added and stirred for 2 hours. The precipitated solid was filtered, and the solid was washed with water and diethyl ether. Further purification by column chromatography gave 32.2 g of the title compound 2. Synthesis Example 3

將30g(0.065 mol)化合物2溶於400ml乙醇中,加入 0.3g的5重量%的碳催化劑和5.〇g(〇.l mol)肼一水合 物,過熱回流6小時。將反應溶液倒入大過量的水中,過 -36- 200907513 濾析出物。將所得固體再通過乙醇進行再結晶,得到l6 9g 目標化合物3 (特定化合物)。 合成例430 g (0.065 mol) of the compound 2 was dissolved in 400 ml of ethanol, and 0.3 g of a 5% by weight carbon catalyst and 5. 〇g (〇.l mol) of hydrazine monohydrate were added, and the mixture was heated under reflux for 6 hours. The reaction solution was poured into a large excess of water and filtered through -36-200907513. The obtained solid was recrystallized from ethanol to obtain 169 g of the objective compound 3 (specific compound). Synthesis Example 4

ClCl

ο 0、ο 0,

ο 將 15g(0.037 mol)化合物 3、200 ml DMSO、41.4g(0.3 m o 1)碳酸鉀混合。將該溶液在冰浴中冷卻後,滴加2 7.8 g (〇 . 3 mol)環氧氯丙烷的DMS◦溶液200 ml。滴加結束後回升至 室溫’繼續攪拌4 8小時。過濾反應溶液,將濾液用旋轉蒸 發器濃縮’再通過真空栗除去過量添加的環氧氯丙院。向 所得粗產物中加入300 ml甲苯稀釋,將該溶液用300 ml 蒸餾水洗滌4次。加入硫酸鈉,放置一夜後,瀘出硫酸鈉 ,採用旋轉蒸發器除去溶劑。將所得粗產物通過氧化矽凝 膠管柱層析進行精製’得到16.2g化合物4(特定化合物B) 合成例5 (特定聚醯胺酸A的合成) 將7.84g(0.04莫耳)作爲四羧酸二酐的1,2,3,4-環丁烷 四羧酸二酐,16g(0.04莫耳)作爲二胺化合物的化合物3溶 於180g N-甲基-2-吡略烷酮中,使其在4〇t:下反應3小時 。接著,將反應溶液注入到大過量的甲醇中,使反應產物 -37- 200907513 沉源。然後,用甲醇洗滌’通過在減壓下於4〇c乾燥15 小時,得到1 2g聚醯胺酸(其作爲“特定聚醯胺酸A”)° 合成例6 將作爲四竣酸二酐的2,3,5 -二竣基環戊基醋酸一肝 112.09g(0.50 莫耳)和 l,3,3a,4,5,9b -六氫-8-甲基 _5_(四氫 -2,5-二氧代-3-呋喃基)-萘H,2-c]呋喃-1,3-二酮 157.15g(0.50莫耳),作爲二胺化合物的對苯二胺 93.54g(0.865 莫耳)、3,3,-(四甲基二矽氧烷二基)二( 丙胺)24.8 5 g(0.10莫耳)和3,6-二(4-胺基苯甲醯氧基)膽固 烷12.86g(0.02莫耳)、作爲單胺的正十八烷基胺8.09g(0.03 莫耳)溶於4500g N -甲基-2 -吡咯烷酮中,使其在6(TC下反 應6小時。接著,將反應溶液注入到大過量的甲醇中,使 反應產物沉澱。然後,用甲醇洗滌,通過在減壓下於40°C 乾燥15小時,得到3 80g對數黏度爲0.80 dl/g的聚醯胺酸 。將所得聚醯胺酸30g溶於570g N-甲基-2-吡咯烷酮中, 加入23.4g吡啶和1 8. lg醋酸酐,使其在1 1 〇°C下脫水閉環 4小時’與上述同樣地進行沉澱、洗滌、減壓,得到1 8 聚醯亞胺(其作爲“聚醯亞胺(a - 1) ”)。 合成例7 將作爲四羧酸二酐的2,3,5-三羧基環戊基醋酸二酉干 224.1 7g(1.0莫耳),作爲二胺化合物的對苯二胺 l〇8.l4g(1.0莫耳)和3,5_二胺基苯甲酸膽固院基陶 7.842g(0.015莫耳)溶於45〇〇gN_甲基_2_吡咯烷酮中,使其 在60°C下反應6小時。接著,將反應溶液注入到大過量的 -38- 200907513 甲醇中’使反應產物沉澱。然後,用甲醇洗滌,通過在減 壓下於40 °C乾燥15小時’得到40 0g對數黏度爲0.75 dl/g 的聚醯胺酸。將所得聚醯胺酸30g溶於570g N -甲基-2-D比 咯烷酮中,加入2 3.4 g吡啶和丨8 ·丨g醋酸酐,使其在u 下脫水閉環4小時’與上述同樣地進行沉澱、洗滌、減壓 ’得到1 9.2 g聚醯亞胺(其作爲“聚醯亞胺(a — 2) ”)。 合成例8 將作爲四羧酸二酐的1,2,3,4 -環丁烷四羧酸二酐 196_12g(1.0莫耳)’作爲二胺化合物的2,2’-二甲基_4,4,· 二胺基聯苯212.3g(1.0莫耳)溶於4500g N -甲基- 2-Π比咯院 酮中,使其在40 °C下反應3小時。接著,將反應溶液注入 到大過量的甲醇中’使反應產物沉澱。然後,用甲醇洗滌 ,通過在減壓下於4 0 °C乾燥1 5小時,得到3 9 0 g聚醯胺酸 (其作爲“聚醯胺酸(b_ 1)”)。 實施例1 將合成例6中製得的聚醯亞胺(a - 1)和合成例8中製 得的聚醯胺酸(b_ 1)以聚醯亞胺:聚醯胺酸=20:80(重量比 )溶解於γ-丁內酯/N-甲基-2-吡咯烷酮/丁基溶纖劑混合溶 劑(重量比71/1 7/12)中’相對於100重量份聚合物加入2 重量份 Ν,Ν,Ν’,Ν’-四縮水甘油基-4,4’-二胺基二苯基甲烷 ,並相對於1〇〇重量份聚合物加入10重量份化合物4,製 成固體成分濃度爲3.5重量%的溶液和6.0重量%的溶液。 將各溶液充分攪拌後,用孔徑爲1 μηα的濾器過濾,調製出 本發明的液晶配向劑。 -39- 200907513 採用旋塗機將上述液晶配向劑中固體成分濃度爲3.5 重量%的溶液塗敷於厚度爲1 mm的玻璃基板的一面上所設 置的由ITO膜所構成之透明導電膜上(轉速:2500rpm,塗 敷時間:1分鐘),在200°C下乾燥1小時,形成乾燥膜厚 爲0.08 μιη的覆膜。採用裝有纏繞人造纖維製之布的輥的打 磨機,在輥轉速爲400 rpm、操作臺移動速度爲3cm/秒, 絨毛押入長度爲〇.4mm的條件下,對該覆膜進行打磨處理 。將上述液晶配向膜塗敷基板在異丙醇中浸漬1分鐘後, 在1 0 0 °C的加熱板上乾燥5分鐘。然後,在一對透明電極/ 透明電極基板的上述液晶配向膜塗敷基板的具有液晶配向 膜的各外緣上,塗敷加入了直徑爲5·5μηι的氧化鋁球的環 氧樹脂接著劑,然後,使液晶配向膜面相對地重合並壓合 ,使接著劑硬化。接著,通過液晶注入口向基板間塡充向 列型液晶(默克公司製造,MLC-6221),然後用丙嫌酸類光 硬化接著劑將液晶注入口封閉,在基板外側的兩面上貼合 偏光板,製成液晶显示元件。對所得液晶顯示元件的電壓 保持率評價和殘影評價按照以上所述的方法進行。 採用固體成分濃度爲6.0重量%的溶液,按照以上所述 的方法進行印刷性評價。 實施例2 將合成例7中製得的聚醯亞胺(a — 2)溶於Ν-甲基-2-吡 略院酮/ 丁基溶纖劑混合溶劑(重量比5 0 / 5 0)中,相對於1 〇 〇 重量份聚醯亞胺(a— 2)加入2重量份^>1’,>^,-四縮水甘 油基-4,4’-二胺基二苯基甲烷,相對於丨00重量份聚醯亞胺 -40- 200907513 (a — 2)加入10重量份化合物4(特定化合物b),製成固體成 分濃度爲3 · 5重量%的溶液和6 · 0重量%的溶液。將各溶液 充分攪拌後,用孔徑爲1 m的濾器過濾,調製出本發明的 液晶配向劑。液晶顯不兀件的製作方法、液晶顯示元件的 評價方法以及配向劑印刷性評價方法以與實施例1相同的 方法進行。 實施例3 將合成例6中製得的聚醯亞胺(a - 1)和特定聚醯胺酸 A以聚醯亞胺:特定聚醯胺酸A = 20:80(重量比)溶解於γ_ 丁內酯/Ν-甲基-2-吡咯烷酮/丁基溶纖劑混合溶劑(重量比 7 1/17/1 2)中,相對於1〇〇重量份聚醯亞胺和特定聚醯胺酸 Α的合計量,加入2重量份Ν,Ν,Ν’,Ν’-四縮水甘油基-4’4 二胺基二苯基甲烷,製成固體成分濃度爲3 · 5重量%的溶液 和6.0重量%的溶液。將各溶液充分攪拌後,用孔徑爲1 Μ"" 的濾器過濾’調製出本發明的液晶配向劑。 比較例1〜4 一 聚醯亞胺、聚醯胺酸、特定化合物係使用表1中所Β 載的物質,按照與實施例1同樣的流程進行。 -41- 200907513ο 15 g (0.037 mol) of compound 3, 200 ml of DMSO, 41.4 g (0.3 m o 1) of potassium carbonate were mixed. After cooling the solution in an ice bath, 200 ml of a solution of 27.8 g (〇. 3 mol) of epichlorohydrin in DMS was added dropwise. After the completion of the dropwise addition, the temperature was raised to room temperature and stirring was continued for 4 hours. The reaction solution was filtered, and the filtrate was concentrated with a rotary evaporator. The excess added epichlorohydrin was removed by vacuum pump. The obtained crude product was diluted with 300 ml of toluene, and the solution was washed 4 times with 300 ml of distilled water. After adding sodium sulfate and allowing to stand overnight, sodium sulfate was decanted and the solvent was removed using a rotary evaporator. The obtained crude product was purified by ruthenium gel column chromatography to obtain 16.2 g of Compound 4 (Specific Compound B). Synthesis Example 5 (Synthesis of specific poly-proline A) 7.84 g (0.04 mol) was used as tetracarboxylic acid 1,2,3,4-cyclobutanetetracarboxylic dianhydride of acid dianhydride, 16 g (0.04 mol) of compound 3 as a diamine compound, dissolved in 180 g of N-methyl-2-pyrrolidone, It was allowed to react for 3 hours at 4 Torr. Next, the reaction solution was poured into a large excess of methanol to cause the reaction product -37-200907513 to sink. Then, washing with methanol was carried out by drying at 4 ° C for 15 hours under reduced pressure to obtain 12 g of polylysine (as "specific polyamido acid A"). Synthesis Example 6 As tetradecanoic acid dianhydride 2,3,5-dimercaptocyclopentyl acetic acid-hepatic 112.09 g (0.50 mol) and l,3,3a,4,5,9b-hexahydro-8-methyl_5_(tetrahydro-2, 5-dioxo-3-furanyl)-naphthalene H,2-c]furan-1,3-dione 157.15 g (0.50 mol), as a diamine compound, p-phenylenediamine 93.54 g (0.865 mol) , 3,3,-(tetramethyldioxanediyl)di(propylamine) 24.8 5 g (0.10 mol) and 3,6-bis(4-aminobenzylideneoxy)cholate 12.86 g (0.02 mol), 8.09 g (0.03 mol) of n-octadecylamine as a monoamine was dissolved in 4500 g of N-methyl-2-pyrrolidone, and allowed to react at 6 (TC for 6 hours). The reaction solution was poured into a large excess of methanol to precipitate a reaction product, and then washed with methanol and dried at 40 ° C for 15 hours under reduced pressure to obtain 3 80 g of polyamine having a logarithmic viscosity of 0.80 dl/g. 30 g of the obtained polyamic acid was dissolved in 570 g of N-methyl-2-pyrrolidone, and 23.4 g of pyridine and 1 were added. 8. lg acetic anhydride was dehydrated and closed at 11 ° C for 4 hours. Precipitation, washing and decompression were carried out in the same manner as above to obtain 18 polyimine (which was used as "polyimine" (a - 1) ”. Synthesis Example 7 2,3,5-tricarboxycyclopentylacetic acid dioxime as tetracarboxylic dianhydride 224.1 7 g (1.0 mol), p-phenylenediamine as a diamine compound 8.l4g (1.0 mol) and 3,5-diaminobenzoic acid cholesteryl pottery 7.482 g (0.015 mol) dissolved in 45 〇〇g N_methyl_2_pyrrolidone, making it at 60 ° The reaction was carried out for 6 hours at C. Next, the reaction solution was poured into a large excess of -38-200907513 methanol to precipitate the reaction product. Then, it was washed with methanol, and dried at 40 ° C for 15 hours under reduced pressure to obtain 40 0 g. Poly-proline with a logarithmic viscosity of 0.75 dl/g. 30 g of the obtained polylysine was dissolved in 570 g of N-methyl-2-D pyrrolidone, and 23.4 g of pyridine and 丨8·丨g acetic anhydride were added. The mixture was dehydrated and closed under u for 4 hours 'precipitation, washing, and reduced pressure in the same manner as above to obtain 19.2 g of polyimine (as "polyimine (a-2)"). will be used as 1,2,3,4-cyclobutanetetracarboxylic dianhydride of tetracarboxylic dianhydride 196_12 g (1.0 mol)' as a diamine compound 2,2'-dimethyl-4,4,diamine The phenyl benzene 212.3 g (1.0 mol) was dissolved in 4500 g of N-methyl-2-pyrrolidone and allowed to react at 40 ° C for 3 hours. Next, the reaction solution was poured into a large excess of methanol to precipitate the reaction product. Then, it was washed with methanol, and dried at 40 ° C for 15 hours under reduced pressure to obtain 390 g of polylysine (as "polyglycine (b-1)"). Example 1 Polyimine (a-1) obtained in Synthesis Example 6 and polylysine (b-1) obtained in Synthesis Example 8 were obtained by polyimine: polyglycine = 20:80 (weight ratio) dissolved in γ-butyrolactone / N-methyl-2-pyrrolidone / butyl cellosolve mixed solvent (weight ratio 71 / 1 7 / 12) 'add 2 parts by weight relative to 100 parts by weight of polymer Ν , Ν, Ν ', Ν'-tetraglycidyl-4,4'-diaminodiphenylmethane, and 10 parts by weight of compound 4 is added relative to 1 part by weight of the polymer to give a solid concentration of 3.5% by weight solution and 6.0% by weight solution. After the respective solutions were thoroughly stirred, they were filtered through a filter having a pore size of 1 μηα to prepare a liquid crystal alignment agent of the present invention. -39- 200907513 A solution having a solid concentration of 3.5% by weight in the above liquid crystal alignment agent was applied onto a transparent conductive film made of an ITO film provided on one surface of a glass substrate having a thickness of 1 mm by a spin coater ( Rotation speed: 2500 rpm, coating time: 1 minute), and drying at 200 ° C for 1 hour to form a film having a dry film thickness of 0.08 μm. The coating was subjected to a sanding treatment using a roller equipped with a roll of rayon-made cloth at a roller rotation speed of 400 rpm, a table moving speed of 3 cm/sec, and a fluffing length of 〇.4 mm. The liquid crystal alignment film-coated substrate was immersed in isopropyl alcohol for 1 minute, and then dried on a hot plate at 100 ° C for 5 minutes. Then, on each of the outer edges of the liquid crystal alignment film of the liquid crystal alignment film coating substrate of the pair of transparent electrode/transparent electrode substrates, an epoxy resin adhesive having an alumina ball having a diameter of 5·5 μm is applied. Then, the liquid crystal alignment film surface is relatively heavily combined and pressed to harden the adhesive. Then, the liquid crystal injection port is used to fill the inter-substrate between the substrates (manufactured by Merck & Co., MLC-6221), and then the liquid crystal injection port is closed with a acrylic acid-based photohardening adhesive, and the polarized light is bonded to both sides of the substrate. The board is made into a liquid crystal display element. The voltage retention evaluation and the afterimage evaluation of the obtained liquid crystal display element were carried out in accordance with the method described above. The printability evaluation was carried out by the method described above using a solution having a solid concentration of 6.0% by weight. Example 2 The polyimine (a-2) obtained in Synthesis Example 7 was dissolved in a mixed solvent of Ν-methyl-2-pyrrolidone/butyl cellosolve (weight ratio 5 0 / 50). 2 parts by weight of >1', >^,-tetraglycidyl-4,4'-diaminodiphenylmethane, relative to 1 part by weight of polyimine (a-2), relative 00 parts by weight of polyamidiamine-40-200907513 (a-2), 10 parts by weight of compound 4 (specific compound b) is added to prepare a solution having a solid concentration of 3 · 5 % by weight and 6.0% by weight Solution. Each of the solutions was thoroughly stirred, and then filtered through a filter having a pore size of 1 m to prepare a liquid crystal alignment agent of the present invention. The method for producing a liquid crystal display, the method for evaluating a liquid crystal display element, and the method for evaluating the printability of an alignment agent were carried out in the same manner as in the first embodiment. Example 3 The polyimine (a-1) and the specific polyamic acid A prepared in Synthesis Example 6 were dissolved in γ_ by polyimine: specific polyaminic acid A = 20:80 (weight ratio). In a mixed solvent of butyrolactone/Ν-methyl-2-pyrrolidone/butyl cellosolve (weight ratio 7 1/17/1 2), relative to 1 part by weight of polyimine and specific polyphosphonium In total, 2 parts by weight of hydrazine, hydrazine, hydrazine, Ν'-tetraglycidyl-4'4 diaminodiphenylmethane was added to prepare a solution having a solid concentration of 5.3 wt% and 6.0 wt%. The solution. After the respective solutions were thoroughly stirred, the liquid crystal alignment agent of the present invention was prepared by filtration using a filter having a pore size of 1 Μ "". Comparative Examples 1 to 4 - Polyimine, polylysine, and specific compounds were used in the same manner as in Example 1 except that the materials described in Table 1 were used. -41- 200907513

表1 聚醯亞胺 聚醯胺酸 特定化合物 電壓保持率 殘影 印刷性 實施例1 a— 1 b-1 特定化合物B >99% 〇 〇 實施例2 a-2 — 特定化合物B >99% 〇 〇 實施例3 a—1 待定聚醯胺酸A 無 >99% 〇 〇 比較例1 a—1 b— 1 Μ >99% X 〇 比較例2 a-l b— 1 化合物A 98% △ X 比較例3 a-2 _ 無 >99% X 〇 比較例4 a-2 一 化合物A 98% Δ X 表中,〇:優,△:良,χ :差。 以下,本發明將以在半導體製造裝置中做爲移送氣體 圖顯示的箭頭Y的方向做爲前後方向。 【圖式簡單說明】 第1圖是爲殘影試驗而製作的帶有ITO電極的晶胞的 說明圖。 【主要元件符號說明】 。 -42-Table 1 Polyimine polyamine specific compound voltage retention rate afterimage printing Example 1 a-1 b-1 specific compound B > 99% 〇〇 Example 2 a-2 - specific compound B > 99 % 〇〇 Example 3 a-1 To be determined poly-proline A No > 99% 〇〇 Comparative Example 1 a-1 b-1 Μ > 99% X 〇 Comparative Example 2 al b-1 Compound A 98% △ X Comparative Example 3 a-2 _ none > 99% X 〇 Comparative Example 4 a-2 A compound A 98% Δ X In the table, 〇: excellent, △: good, χ: poor. Hereinafter, the present invention will use the direction of the arrow Y displayed as a transfer gas pattern in the semiconductor manufacturing apparatus as the front-rear direction. BRIEF DESCRIPTION OF THE DRAWINGS Fig. 1 is an explanatory view of a unit cell with an ITO electrode prepared for the image sticking test. [Main component symbol description]. -42-

Claims (1)

200907513 -、申請專利範圍: 一種液晶配向劑,其特徵在於包括:由下述式(A )表示的 重複單元所構成的聚醯胺酸與由下述式(B)表示的重複 單元所構成的聚醯亞胺的混合物,或者由下述式(B)表示 的重複單元所構成的聚醯亞胺;以及下述式(1 )表示的化 合物, HOOC Vhnoc200907513 - Patent Application Range: A liquid crystal alignment agent comprising: a polylysine composed of a repeating unit represented by the following formula (A) and a repeating unit represented by the following formula (B) a mixture of polyimine or a polyimine composed of a repeating unit represented by the following formula (B); and a compound represented by the following formula (1), HOOC Vhnoc C00H CON Η—Q1C00H CON Η—Q1 (A) P1爲4價的有機基團,且Q1爲2價的有機基團;(A) P1 is a tetravalent organic group, and Q1 is a divalent organic group; X1—SX1—S P2爲4價的有機基團,且Q2爲2價的有機基團; R1 R1 =卜 Y-/)—S一X2 (1) 式中,2個R1各自獨立地爲氫、烷基、烷氧基或胺基, Y爲-S-、-NH-、-0-、-CH2-或單鍵中的任意一種,X1和 X2各自獨立地爲下述結構中的任意一種; -43- 200907513P2 is a tetravalent organic group, and Q2 is a divalent organic group; R1 R1 =Bu Y-/)-S-X2 (1) wherein, two R1 are each independently hydrogen, alkyl, or alkane An oxy group or an amine group, Y is any one of -S-, -NH-, -0-, -CH2- or a single bond, and X1 and X2 are each independently one of the following structures; -43- 200907513 基或二縮水甘油基胺基。 2 _如申請專利範圍第1項之液晶配向劑,其中上述式(丨)中 ’ 2個R1均爲氫,且Z1、Z2或Z3均爲二縮水甘油基胺 基。 3 ·如申請專利範圍第1項之液晶配向劑,其中上述式〇 )中 ,2個R1均爲氫,且Z1、Z2或Z3均爲氫。 4 ·如申請專利範圍第1項之液晶配向劑,其中上述式(A)中 的P1和上述式(B)中的P2均來自於2,3,5-三羧基環戊基 醋酸二酐。 i 5.—種液晶配向劑,其特徵在於包括:由上述式(A)表示的 重複單元所構成的聚醯胺酸與由上述式(B)表示的重複 單元所構成的聚醯亞胺的混合物,或者由上述式(B)表示 的重複單元所構成的聚醯亞胺;以及由上述式(1)中2個 R1均爲氫、且Z1、Z2或Z3均爲胺基的化合物與四羧酸 二酐反應所得的聚醯胺酸聚合物,或者使所得聚酿胺酸 聚合物脫水閉環而得到的聚醯亞胺。 6 · —種液晶顯示元件’其特徵在於具有由申請專利範圍第1 至5項中任一項之液晶配向劑所製得的液晶配向膜。 -44-Base or diglycidylamino group. The liquid crystal alignment agent of claim 1, wherein in the above formula (丨), two R1 are hydrogen, and Z1, Z2 or Z3 are diglycidylamino groups. 3. The liquid crystal alignment agent of claim 1, wherein in the above formula ,), two R1 are hydrogen, and Z1, Z2 or Z3 are all hydrogen. 4. The liquid crystal alignment agent of claim 1, wherein P1 in the above formula (A) and P2 in the above formula (B) are both derived from 2,3,5-tricarboxycyclopentyl acetic acid dianhydride. i. A liquid crystal alignment agent comprising: a polyamidene composed of a repeating unit represented by the above formula (A) and a polyimine composed of the repeating unit represented by the above formula (B) a mixture, or a polyimine composed of the repeating unit represented by the above formula (B); and a compound of the above formula (1) wherein both R1 are hydrogen and Z1, Z2 or Z3 are amine groups A polyaminic acid polymer obtained by reacting a carboxylic acid dianhydride or a polyimine obtained by dehydrating a closed polyamic acid polymer. A liquid crystal display element is characterized in that it has a liquid crystal alignment film produced by the liquid crystal alignment agent of any one of claims 1 to 5. -44-
TW097118604A 2007-05-23 2008-05-21 Liquid crystal alignment agent and liquid crystal display device TW200907513A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP2007137118 2007-05-23

Publications (1)

Publication Number Publication Date
TW200907513A true TW200907513A (en) 2009-02-16

Family

ID=40100493

Family Applications (1)

Application Number Title Priority Date Filing Date
TW097118604A TW200907513A (en) 2007-05-23 2008-05-21 Liquid crystal alignment agent and liquid crystal display device

Country Status (4)

Country Link
JP (1) JP5099351B2 (en)
KR (1) KR20080103444A (en)
CN (1) CN101311797A (en)
TW (1) TW200907513A (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2019044795A1 (en) * 2017-08-29 2019-03-07 日産化学株式会社 Liquid crystal alignment agent, liquid crystal alignment film, and liquid crystal display element

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH05263077A (en) * 1992-03-17 1993-10-12 Japan Synthetic Rubber Co Ltd Agent for aligning liquid crystal

Also Published As

Publication number Publication date
JP5099351B2 (en) 2012-12-19
JP2009003426A (en) 2009-01-08
KR20080103444A (en) 2008-11-27
CN101311797A (en) 2008-11-26

Similar Documents

Publication Publication Date Title
TWI386434B (en) Liquid crystal orientation agent and liquid crystal display element
TWI454805B (en) Liquid crystal aligning agent and liquid crystal aligning element
JP4978433B2 (en) Liquid crystal aligning agent and liquid crystal display element
TW200903115A (en) Liquid crystal alignment agents and liquid crystal display elements
TWI433870B (en) Liquid crystal aligning agent and liquid crystal display element
TWI476489B (en) Liquid crystal aligning agent and liquid crystal display element
TW200903116A (en) Liquid crystal aligning agent and liquid crystal display
TWI501011B (en) Liquid crystal aligning agent and liquid crystal display element
TWI467290B (en) Liquid crystal aligning agent, liquid crystal display element, polyamic acid, polyimide and compound
TW200930747A (en) Liquid crystal aligning agent and liquid crystal display element
TWI358006B (en) Liquid crystal alignment agent and liquid crystal
TWI439770B (en) Liquid crystal alignment agent and liquid crystal alignment film
JP2008090297A (en) Liquid crystal aligning agent and liquid crystal display element
TWI442144B (en) Liquid crystal alignment agent and liquid crystal display element
TW200819510A (en) Liquid crystal alignment agent, liquid crystal alignment film and liquid crystal display element
TWI461460B (en) Liquid aligning agent liquid crystal aligning film and liquid crystal display element
JP2008225458A (en) Liquid crystal aligning agent and liquid crystal display element
JP4978434B2 (en) Liquid crystal aligning agent and liquid crystal display element
TWI354843B (en) Liquid crystal alignment agent and liquid crystal
TW200932789A (en) Liquid crystal aligning agent, liquid crystal aligning film and liquid crystal display element
TWI480313B (en) Liquid crystal aligning agent and liquid crystal display element
TWI457421B (en) Liquid crystal alignment agent, liquid crystal alignment film and liquid crystal display element
TWI422930B (en) Liquid crystal alignment agent and liquid crystal display element
JP2008216671A (en) Liquid crystal aligning agent and liquid crystal display element
TW200925181A (en) Liquid crystal alignmenting agent and transverse electric field type liquid crystal display element